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THE ROLE OF FOLLI CULAR DENDR I T I C  CELLS IN HUMAN 
IMMUNODEF I C I ENCY VIRUS PATHOGENES I S  
Sonya Lynn Heat h ,  M . S .  
A t hes i s  submit ted in part ial ful f i l lment o f  t he 
requi rements for t he degree o f  Mas ter o f  Sc ience at Vi rginia 
Commonweal t h  Univers ity . 
V i rginia Commonwea l t h  Univer s i ty , 1 9 9 5 . 
Maj or D i rector : Dr . Gregory F .  Burton Ph . D . , As s i s tant 
Professor , Department of Mi crobiology and Immuno l ogy 
I n fec t ion w i t h  Human Immunodef i c iency V i rus - 1 ( H I V )  
res u l t s  in a di sease process characteri zed by three stages : an 
acute phase character i z ed by v i remi a ,  a c l i n i cal l y  l atent 
s t age w i t h  l i t t le or no detec t ion o f  v i rus in t he b l ood , and 
t he last stage , AIDS , which i s  characteri zed by marked 
immunodef i c iency . During c l inical latency , CD4+ T cel l s  
dec l i ne over a peri od las t i ng f rom a few t o  several years . 
Throughout t h i s  period , HIV i s  f ound trapped on the surface o f  
f o l l i cular dendri t i c cel l s  ( FD C )  in the germinal centers o f  
secondary lympho id t i s sues and t h i s  i s  the primary s i te o f  
act i ve v i ral rep l i cat i on . We hypothes i ze t hat FDC , and t he 
unique mic roenvi ronment t hey help provide , p l ay a c r i t i cal 
role i n  H IV pathogenes i s . The obj ect ive of t hese s tudies was 
to begin to c haracter i z e  t he role of FDC in HIV pathogenes i s  
x 
by det e rmin ing i f  H I V  immune comp lexe s t rapped on FDC are 
infe c t i ou s . 
To begin t o  t e s t  thi s , HIV ( I I I B )  immune comp lexe s were 
f o rmed by i ncubat ing v i ru s  with serum f rom HIV i n f e c t ed 
individua l s  as a source o f  virus - spec i f i c  ant ibody . Highly 
enriched t ons i lar FDC ( from non - infected individual s )  were t hen 
incubated with t hese HIV-comp l exes to al low FDC t rapp i ng in 
vitro. H I V  binding to FDC was con f i rmed by e le c t ron 
microscopy ( EM )  . Unbound HIV was removed by washing t he ce l l s  
and FDC bearing HIV immune comp l exe s o r  cont rol FDC we re 
c u l tured for four days with superant igen act ivated , FACS 
sorted , aut o l ogous CD4+ tonsi lar T lymphocyte s  to det e rmine i f  
the T ce l l s  cou l d  be infected by t he FDC t rapped virus . H IV 
infect ion was detected us ing PCR amp l i f i cat ion of provi ral gag 
s equences t hat woul d  be present in DNA i so l at e d  f rom the 
c u l ture s . To ensure t hat our in vitro cul tures were 
representat ive of in vivo event s ,  we used a xenogene i c  mode l 
where H I V  immune comp l exes were formed and t rapped on mur i ne 
FDC in vivo. I mmune comp l exes were formed by inj e c t ion o f  
v i rus - spe c i f i c  ant ibody fol lowed by HIV ( I I I B ) . Mur i ne FDC 
bear ing H IV t rapped in vivo were i so lated and i ncubat e d  w i t h  
act ivat ed human CD4+ T cel l s  a s  t he only source of v i ru s  for 
infect ion . Infect ion was asses sed as be fore . HIV infect ion of 
xi 
T c e l l s  was de t e c t ed i n  cul tures cont aining FDC bearing HIV 
immune comp l exes t rapped i n  vitro whe reas no infect ion was 
detected in cont ro l s . Furthermore, murine FDC bearing in vivo 
t rapped H I V  immune comp l exe s also infected human CD4 + T c e l l s . 
I n  s ome in vivo experiments, HIV immune comp l exes we re 
formed u s i ng a neut ral i z ing ant ibody that cou l d  b l oc k  
infect ion . F D C  bearing these neutra l i zed HIV immune comp l exes 
a l so t r ansmi t ted infect ion to T ce l l s . Thi s  prompted the 
hypothe s i s  that FDC may be able to negate the e f f e c t s  of 
neut ral i z ing ant ibody . To t e s t  this, we formed HIV immune 
comp l exes with several dos e s  ( p i cogram to mi l l igram) o f  
neut ral i z ing ant ibody and cultured the s e  with T c e l l s  ± FDC . 
No i n f e c t ion was present in cul tures o f  immune comp l exes and 
T ce l l s  wi thout FDC, however, infect ion was c l e ar ly seen when 
FDC we re added . Furthermore, ne i the r macrophages, dendr i t i c  
c e l l s, nor FDC dep l eted populat ions o f  t ons i l ar c e l l s  could 
rep l ace FDC i n  negat ing the e f fe c t  o f  neut ral i z ing ant ibody 
and this e f fect cou ld be observed with d i f ferent neut ral i z ing 
ant i bodi e s  and several s t rains o f  v i rus inc luding a prima ry 
i so l a t e . 
These data indi cate that FDC associated HIV i s  infect i ou s  
and t h a t  F D C  c a n  negate the e f fe c t s  o f  high leve l s  o f  
neut r a l i z i ng ant ibody thus permi t t ing infect ion t o  occur . 
Thi s  f inding may help exp l a i n  why HIV infected individua l s  
x i i  
w i t h  neut ral i z ing ant ibody s t i ll have ongoing i n f e c t i on . I n  
add i t i on ,  this data may cause us to re shape our think ing about 
vac c inat ion and t reatment s t rategi e s . F i nally , t h i s  work 
supports our hypothe s i s  t hat FDC play an important role in HIV 
pathogene s i s . 
Background & Significance 
Human Immunodeficiency Vi rus 
H uman immunod e f i c i e n c y  vi rus ( H I V) ,  i s  the  e t i o l og i c  
agent o f  acqui red immunode f i c i ency s yndrome ( AI DS) [ 1 ] . I t  i s  a 
memb e r  o f  t he l e n t i vi r u s  sub fami l y  o f  r e t rovi r u s e s . 
Re t rovi r u s e s  a r e  c h a r a c t e r i z e d  by t he i r  abi l i t y  t o  conve r t  
t h e i r  RNA genome i n t o  DNA a n d  t hen i n t e g r a t e  t h i s  DNA 
( r e f e r red to a s  t h e  prov i r us) i n t o  the  h o s t  ce l l s ' ge nome . 
V i r u s e s  w i t h i n  t h e  l e n t i v i rus s ub f ami l y  a r e  a s s o c i a t ed w i t h  
s l ow progres s i n g ,  i n f l amma t ory and degenerat ive disorde r s . H I V  
i s  a bl ood borne and/or  muc o s a l  pathoge n ,  t h a t  i s  t ra n smi t t e d  
by s e x u a l  cont a c t , p a r e n t e r a l  expos u r e  t o  b l ood ( mo s t l y  b y  
i n t ravenous  drug u s e r s) ,  and f r om mot h e r  t o  c h i l d  d u r i ng 
pregnancy and a t  p a r t u r i t ion . There current l y  i s  no e ffe c t ive 
t re a tmen t  o r  c u r e  f o r  A I DS [ l ]  
Virus Lif e Cycle 
T h e  l i f e  c y c l e  o f  H I V  c lo s e l y  f o l l ows t h a t  o f  a l l  o t h e r  
memb e r s  o f  t h e  l e n t i v i r u s  fami l y . I t  b e g i n s  by v i r u s  b i n d i n g  
t o  h o s t c e l l  r e cept o r s . I n  the  c a s e  o f  H I V  t h i s  b i nd i n g  i s  
med i a t e d  by gp 1 2 0  on the s u r f ace o f  the v i r a l  enve l ope . Gp 1 2 0  
1 
2 
a t t a c h e s  t o  the  C D 4  mol ecule  o f  the t a rget  ce l l ,  the  T h e l p e r  
l ymph o c y t e [ 2 - 4 ) Fo l l ow i n g  r e c e p t o r  bindi n g ,  the  v i r u s  
p e n e t r a t e s  t h e  c e l l  membrane a n d  uncoa t i ng o f  t h e  v i r u s  
e n v e l ope and n u c l e o c a p s i d  occurs  i n  the  c y t op l a sm .  A f t e r  
uncoa t i n g  i n s i de a n  a c t i v a t e d  h o s t  c e l l ,  v i r i o n  a s s o c i a t ed 
reve r s e  t ra n s c r i p t a s e  r e ve r s e  t r a n s c r i b e s  v i r a l  RNA i n t o  
doub l e  s t r a nded DNA a n d  v i r a l l y  encoded i n t e g r a s e  a l l ows  t h e  
i n t e g ra t i on o f  t h e  p r o v i r u s  i n t o  t he ho s t ' s genome . Once 
i n t e g ra t i on has occur red , HIV can  r ema i n  l a t e n t  in t h e  
p rovi r a l  i nt e g r a t e d  s t age o r  a l t e r n a t i ve l y  be a c t i ve l y  
repl i c a t e d [ l ) . I n  the  l a t t e r  i n s t ance , ce l l u l a r  t r a n s c r ipt i on 
events  c a u s e  exp re s s i on o f  the v i r a l  regu l a to r y  prote i n s . H I V  
ends  i t s  l i f e c y c l e  b y  budd i n g  o u t  o f  t h e  h o s t  ce l l ' s p l a sma 
memb r a n e  where it acqu i re s  a l i p i d  enve l ope . 
Latency 
B o t h  c l i n i c a l  and v i r o l o g i c a l  l a t e n c y  p l a y  impo r t a n t  
r o l e s  i n  t h e  p e r s i s tence o f  H I V  i n f e c t ion . C l i n i c a l  l a t e n c y  
i s  d e f i ne d  a s  t h e  p e r i od o f  d i s e a s e  w h i c h  i s  p r i ma r i l y  
a s ympt oma t i c  
d i s e a s e ") [ 1 )  . 
( di s cu s sed under t he heading " s t a g e s  o f  
I n  contra s t ,  v i r o l o g i c a l  l a tency r e f e r s  t o  t h e  
s t a t e  o f  i n t e g r a t e d  p r o v i r u s  w i t h i n  a ce l l  t h a t  i s  n o t  
a c t i ve l y  e xp r e s s i n g  v i r a l  prot e i n s  o r  rep l i c a t i ng v i ru s [ l ) . 
3 
Evidence t h a t  a s t a t e  o f  v i r o l o g i c a l  l a tency e x i s t s  a n d  t h a t  
t h e  ma j o r i t y  o f  i n t e g r a t e d  provi r u s e s  a r e s i l e nt  come s f r om 
two ob s e rv a t i on s . S c hmi t tman e t . al .  found t h a t  i n  t h e  
p e r i p h e r a l  bl ood t h e r e  i s  a 1 0  fold h i g h e r  f requency o f  C D 4 +  
ce l l s  w i t h  d e t e c t a b l e  H I V  DNA compared t o  ce l l s  a c t ua l l y  
expre s s i n g  H I V  RNA o r  v i r a l  prot e i n s  [ 5 ]  . S imi l a r  f i nding s 
w e r e  a l s o  reported by Emb r e t s o n  e t . al . [ 6 ]  S h e  found a 
h i g h e r  f requency o f  c e l l s  w i t h  H I V  DNA t h a n  HIV RNA i n  
l ymph o i d  t i s s u e . T h i s  s t a t e  o f  v i r a l  l a t ency p r o v i d e s  a 
r e s e rvo i r  o f  l a t e n t l y  in fected  c e l l s  which  upon a c t i v a t i on 
p r oduce H I V . Once H I V  h a s  i n t e g r a t e d  i n t o  t h e  h o s t  ce l l ' s  
ge nome , i t s  expre s s i on depends mo s t l y  on h o s t  a c t i  va t i on 
s i gna l s ,  host  c e l l  mach inery,  s equences within the  HIV ge nome , 
and vari ous v i r a l  protei n s . To ful l y  unde r s t a nd the me chani sms 
i nvolved in v i r a l  repl i c a t i on ,  an  unde r s t a nding of t h e  v i r a l  
genome i s  needed . 
Viral Genome 
The genome of H I V  con t a i n s  the three prototypic genes o f  
l e n t i v i r u s e s , gag, pol, and en v a s  wel l a s  add i t i on a l  g e n e s  
e n c od i n g  r e g u l a t o r y  and a c c e s s o r y  prot e i n s  ( i . e . ,  t a t ,  r e v, 
n ef, vpr, vpu and vif) . These genes a re f l a nked on e i th e r  s i de 
by l ong t e rmi n a l  repe a t s  ( LTR) . H I V  genes can be divided i n t o : 
4 
1 )  e a r l y  genes  - n ef, t a t ,  and rev; and l a t e  genes - gag, pol, 
vif, vpr, an d vpu . 
E arly genes : 
NEF, f i r s t  n amed nega t i ve factor b e c a u s e  i t  was  t h ought 
to  down r e g u l a t e  r ep l i c a t i o n [ 7 - 9 ] , h a s  recen t l y  been l i nked 
w i  th i n c r e a s i n g  v i r a l  r ep l i c a t i on . n ef mu t a n t s  of S im i a n  
Immunod e f i c i e n c y  V i r u s  ( S I V )  demon s t ra t e d  t h a t  t h e  gene  
p roduct w a s  e s s e n t i a l  for  h i g h  viral  rep l i c a t i on a n d  t h e  
deve l opme n t  o f  S imian A I DS [ 1 0 ]  I n  addi t i on , N E F  down 
r e g u l a t e s  C D 4  expre s s i on on  helper  T ce l l s  [ 1 1 ,  1 2 ] . Th i s  
f e a t u r e  h a s  been s hown w i t h  S I V  [ 1 3 ]  and p r ima r y  i s o l a t e s  of 
H I V [ I I ] . The mecha n i sm of down regu l a t ion of C D 4  occurs  a t  the  
p o s t  t r a n s c r i pt i o n a l  l e v e l  [ 1 4 ] . NEF  functions  b y  c a u s i n g  
endocyt o s i s  a n d  degr ada t i on o f  C D 4 . I n  addi t i o n ,  N E F  c a u s e s  
di spl a cemen t  of pS 61yk ( a  tyrosine  k i n a s e ) f rom C D 4 . W h e n  p Seyk 
i s  phospho r y l a t e d ,  i t  t r iggers  T c e l l  a c t i v a t i o n  r e s ul t i n g  i n  
I L- 2  produ c t i on a n d  c e l l  prol ifera t ion . Down regul a t ion o f  C D 4  
i s  i mp o r t a n t  i n  t h a t  i t  preve n t s  mu l t i p l e  i nf e c t i on o f  t h e  
s ame c e ll leading  t o  a s t a t e  o f  super- i n f e c t i o n . Were t h i s  t o  
occu r ,  the  r e s u l t i ng mul t i p l e  copi e s  o f  u n i n t e g r a t ed DNA could 
be tox i c . In  this  manne r ,  N E F  is  t hought to  increase the  l if e  
o f  vi r a l l y  i nf e c t e d  ce l l s . 
5 
TAT, the t ransactiva t or , i s  encoded by two exons that  a r e  
s epa r a t ed f rom e a c h  o t h e r  b y  mu ch o f  the  e n v  gene . S i nce t h e  
g e n e  i s  i n  a di f fe rent reading f rame t h a n  env, i t s  expre s s i on 
requ i r e s  both s p l i c i ng of the t at t ra n s c r ipt and a f r ame s h i f t  
by t h e  ribosome t o  b e  t rans l a t ed i n  t h e  prope r reading f rame . 
A l t hough t h e  e x a c t  me cha n i sm o f  i t s  a c t i o n  i s  un known , TAT 
a c t i v a t e s  t r a n s c r ipt i o n a l  i n i t i a t i on of the  v i r a l  g e ne s . I n  
the  pres ence o f  TAT there i s  a n  i nc re a s e  i n  the  numb e r  o f  f u l l  
l e n g t h  v i r a l  mRNA t r a n s c r ipt s .  W i t hout TAT , the  H I V  p r omo t e r  
p roduce s  many s h o r t  v i r a l  t r a n s c r i p t s  t h a t  c o r r e spond t o  t h e  
T a r  RNA s t eml oop s t r u c t u r e  t h a t  wi l l  b e  de s c r ibed l a t e r  ( s e e  
LTR ) [ 1 5 ] . T a ken toge t h e r , t h i s  sugge s t s  t h a t  TAT may p l ay a 
r o l e  a s  a n  a n t i - t e rmina t o r  o f  t r a n s c r i p t ion [ 1 6 , 1 7 ] . 
REV, t h e  �egul a t or o f  �xp r e s s ion o f  the yi rion , c on t r o l s  
t he t empo r a l  exp r e s s i on o f  the  e a r l y  a n d  l a t e  g e ne s . I t  
i n c re a s e s  exp r e s s i on o f  v i r i on genes  wh i l e  d e c re a s i n g  
expre s s i on o f  regu l a t ory genes [ 1 8 ,  19 ] . REV t a ke s  adva n t a ge o f  
t h e  f a c t  t h a t  ea rly gene produ c t s  a r e  t r ans l a t ed f rom mu l t iply 
s p l i ce d  mRNA ' s wh i l e  late gene produ c t s  are the  r e s u l t of 
u n s p l i c e d  o r  s i n g ly spl i c ed mRNA ' s .  I n  t h e  absence o f  REV , 
mRNA ' s rema i n  i n  the  nucleus . They a r e  e i t h e r  de grade d  t h e r e  
o r  a re mul t i ply s p l i ce d  be fore  being t r an s p o r t e d  t o  t h e  
cyt o p l a sm t o  gene r a t e  the  e a r ly g e n e  produ c t s  [ 1 8 ] . On t h e  
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o t h e r  h a nd , when enough REV h a s  been gene r a t e d ,  i t  w i l l  b i n d  
t o  t h e  RRE , �ev � e s p o n s e  �leme nt i n  t he e n v  s e quence o f  t h e  
mRNA r e s u l t i ng i n  t ransport o f  the mRNA to  the  cyt op l a sm . T h i s  
p r e v e n t s  f u r t h e r  s p l i c i ng a n d  a l l ows t r a n s l a t i on o f  t h e  l a t e  
gene s [ 19 ]  REV provides addi t i onal mechani sms f o r  ma i n t a i n ing 
l a t en cy . L a t e n t ly i n f e c ted c e l l s ,  in  s ome c a s e s , may not h a ve 
a c c umu l a t e d  enough REV to  begin  p r odu c t i on o f  i n f e c t e d  
vi r i on s [ 2 0 ] . T h e r e  a r e  a l s o c e l l u l a r  p r o t e i n s  w h i c h  c a n  b i n d  
the  RRE and b l o c k  b i nding o f  REV . One o f  t h e s e  i s  induced by 
i n t e r f e ron ( I N F )  w h i c h  i s  known t o  prevent  H I V  
r ep l i ca t i on [ 2 1 ]  . T h e s e  me chani sms sugg e s t  t h a t  REV p l ays  a n  
impo r t a n t  r o l e  i n  r e gu l a t i ng H I V  l a t e ncy a n d  a c t i v a t i o n . 
Late genes : 
Once s u f f i c i e nt  REV h a s  a c cumu l a t e d ,  the  l a t e  g e n e s  o f  
H I V  a r e  expre s s e d  and t he v i rus can beg i n  t o  make new v i r ions . 
T h i s  r e qu i r e s  the  use  o f  the three ma in l a t e  genes: gag, pol, 
a n d  en v .  
gag, t h e  group spe c i f i c  �nt igen , encode s t h e  core prot e i n  
or c a p s i d  w h i c h  e n c l o s e s  the  v i r a l  RNA . GAG , i s  t r a n s l a t e d  a s  
a polyp r o t e i n  P r 5 5  w h i c h  i s  c l e aved i n t o  the  ma t r i x ,  caps i d ,  
and nucl eocap s i d  proteins [ 2 2 ] . The ma t r i x  prot e i n ,  o r  p 1 7 , i s  
a c omponent o f  t h e  inner  s u r face o f  the  v i r i on l ip i d  b i l ay e r  
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a n d  t h e  core  s t r u c t u r e . As su ch , i t  pl ays a r o l e  i n  v i r us 
assembly and vi rus e n t ry [ 2 3 ] . The capsid prot e i n ,  p2 4 ,  is 
the ma j o r component of the cone shaped core s t r u c t u r e  wh i ch 
e nc l oses t h e  t w o  st rands o f  v i r a l  RNA . F i na l ly t h e  
nucl eocapsid p r o t e i ns ,  p 9  a n d  p 6 ,  asso c i a t e  w i t h  the  v i r a l  RNA 
and t h is is b e l i eved t o  be a recogn i t ion signal for  pa c ka g ing 
o f  t h e  RNA into a new v i r ion [ 2 4 ] . I n  addi t i on t o  GAG , 
some t imes a GAG / POL fusion p r o t e i n  is produced d u r i n g  
t r a nsl a t i on . T h is occurs w h e n  the  r i bosome "sl i ps b a c k" o n e  
nuc l e o t i de , changing to  the pol reading f rame . S i nce i t  t a kes 
many GAG p r e c u rsors ( approxima t e ly 1 5 0 0 )  to  ma ke t h e  c o r e , 
whi c h  enc l oses t he two strands o f  v i r a l  RNA , and only r e qu i r es 
a few polyme r ase mo l e c u l es for  assemb ly , r i bosoma l 
f r amesh i f t i n g  t o  produce POL only occurs a t  a f r equency o f  1 
i n  2 0  t imes . 
po� encodes the vi rus speci f i c  enzymes: protease , reverse 
t r ansc r i p t ase ( RT ) , and i n t e g rase . The func t i on of vi r a l ly 
encoded prot ease is t o  cl eave the GAG and POL precursors i n t o  
t h e i r  v a r i ous subun i ts . Protease i s  rel eased b y  autoprocessing 
e vents and then is able t o  c l eave the  other  subuni ts [2 5 - 2 8 ] .  
RT h as b o t h  RNA and DNA dependent DNA 2Qlyme rase a c t i v i t i es .  
T h ese a c t i v i t i es a l l ow the  vi rus to  reverse t r ansc r i b e  RNA 
i n t o  DNA and to c opy DNA [ 2 9 , 3 0] .  I n  add i t i o n ,  RT has RNase 
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H a c t i  vi  ty which  degrades the  RNA s t r a nd o f  t h e  RNA- DNA 
hyb r i d [ 3 l , 3 2 ] . T h i s  i s  nece s s a ry to produce t h e  doub l e  
s t ra nded DNA provirus . Fina l ly ,  t h e  funct ion o f  H I V  i n t e g r a s e  
i s  t o  i n s e r t  o r  i n t e g r a t e  the  prov i r a l  DNA i n t o  t h e  h o s t  
c e l l s '  genome [ 3 3 , 3 4 ] I n t e g r a s e  binds  t o  c e l l u l a r  DNA [ 3 5] ,  
kni c k s  i t  u s i n g  i t s  endonuc l e a s e  a c t i v i ty [ 3 5 ] , i n t e g r a t e s  the  
p r ov i r u s , and r e comb i n e s  the  s t rands [ 29 , 3 6 - 3 8 ] 
envencodes the viral  envel ope proteins compri s ing gp1 6 0 . 
T h e  p r oduct  o f  en v i s  b r ought t o  t h e  s u r f a ce o f  t h e  v i rus  
pa r t i c l e  whe r e  a c e l l u l a r  e n zyme c l e aves  the  ma j o r p r odu c t , 
gp 1 6 0 ,  i n t o  i t s  componen t s  gp 1 2 0 ,  the  s u r f a ce ma r ke r  
r e s p on s ib l e  f o r  b i nd i ng C D 4  o n  h o s t  c e l l s ,  and gp4 l ,  t h e  
t ra n smemb r a n e  r e g i on w h i c h  p l ays a major r o l e  i n  v i r u s - h o s t  
c e l l  membrane  fus i on even t s . 
The genes gag, pol, en v, t a t ,  and rev, a r e  e s s e n t i a l  and 
t h e  v i r u s  is unable  to  r ep l i c a t e  u n l e s s  t h e s e  gene p r odu c t s 
a r e  func t i ona l . I n  cont ra s t ,  the gene p roduc t s  n ef, vif, vpr, 
and vpu a r e  not e s s en t i a l  for  repl i ca t ion but a r e  cruc i a l  f o r  
ma i n t a i n i ng v i r a l  spreading . 
vir, t h e  y i r i on .in f e c t i  vi ty .fa c t o r ,  encodes a p r o t e i n  
w h i c h  i n c r e a s e s  i n f e c t i vi ty o f  t he v i rus . vif mut a n t s  p roduce 
v i ru s  wh i c h  i n f e c t s  ce l l s  a thous and t ime s l e s s  e f f i c i e n t ly 
t h a n  v i r u s  w i t h  w i l d  type vif .  Fu r t h e rmore , vif mu t a n t s  a re 
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unable  t o  comp l e t e ly synt hesi ze  provi r a l  ONA [ 3 0 ] . I t  is 
b e l i eved t h a t  VI F pl ays a role in  uncoa t i ng the  v i r us and 
disrupt i n g  t h e  core  thus a l l owing co f a c t o rs o f  RT t o  e n t e r . 
The exact func t i on o f  VPR, yiral  Qrotein X, is not known . 
I t  has been imp l i ca t e d  as : a we a k  t r ansa c t i v a t o r  o f  t h e  H I V  
LTR; a t ransp o r t e r  o f  the nucl eocapsid t o  t h e  nucleus; and a n  
inducer o f  di f fe rent i a t ion a n d  growth a r rest [ 39 ] . Re cent  da t a  
suggests t h a t  V I F i nduces g r o w t h  a r r est o f  i n fe c t ed ce l ls a t  
t h e  G 2  phase o f  t h e  c e l l  cyc l e  wh i ch may p l ay a r o l e  i n  
modu l a t i n g  v i r a l  persist ence [ 39 ] . G 2  a r rest is advant ageous t o  
t h e  v i r us f o r  seve r a l  re asons . G 2  a r r est a l l ows p r ov i r a l  
i n t e g ra t i on ( wh i ch occurs in  t h e  S phase o f  t h e  c e l l  cyc l e )  
a n d  expressi o n  o f  t h e  v i rus; i t  i n c r e ases v i r a l  p r oduc ts; i t  
prevents reent ry o f  c e l ls into  the  GO phase o f  the  c e l l  cyc l e; 
and i t  may p revent apop t osis ( o r a l  p rese nt a t i on ,  Keystone 
C o n f e r e n c e ) . 
T h e  func t i on o f  t h e  v i r a l  prote i n , VPU st i l l  r ema i ns 
l a r g e ly un known . VPU is asso c i a t e d  w i t h  disrup t i n g  gp 1 2 0  f rom 
C 0 4 [ 4 0 , 4 1 ] , and r e l easing H I V  p a r t i c l es [ 4 2 ]  but i t  is n o t  
i nc o rpo r a t e d i n t o  n e w  v i r i ons . The genome o f  H I V  is mo r e  
comp l e x  t h a n  t h a t  o f  most l e n t i v i ruses and each p r o t e i n  p l ays 
a sub t l e  yet important  role  in promot ing and ma i n t a i ning  v i r a l  
i n f e c t i on . 
1 0  
Long terminal repeat: 
The LTR can be divided into  t h ree regi ons based on t h e i r  
r e gu l a t o ry funct ion : l ) the core , 2 )  t h e  modul a t o ry reg i o n ,  and 
3 )  the TAR e l eme n ts . W i  thin t h e  LTR,  sequen ces ex ists wh i c h  
i n i t i a t e  o r  suppr ess t r ansc r i p t i on . These sequen ces a re t h e  
t a rg e t  o f  mu l t i p l e  c e l l u l a r  fa c t o rs w h i c h  a r e  fu r t h e r  
i nfl uenced b y  c e l l u l a r  a c t i va t i on and diffe re n t i a t i o n  of 
ma c r ophages and lymphocytes ,  and by the presence of cyt o k i nes . 
I n  t his way, H I V  has l i n ked i ts expression w i t h  i ts host c e l ls 
r e gu l a t i o n . 
T h e  core  c on t a i ns b i nd i ng s i t es i n c l u d i n g  S Pl a n d  t h e  
TATA b i nd i ng f a c t o r . S Pl a c ts as a st rong t ransc r i p t i on a l  
a c t i v a t o r . T h e  TATA box faci l i t a t e  i n i t i a t i o n  of 
t ransc r ipt i on when bound by c e l l u l a r  RNA polyme r ase I I . The 
TATA box w i t h i n  the  LTR may also b i nd LBP-l ( l e a d e r  b i nd i n g  
prot e i n )  [ 4 3 ] . This interact ion a ct u a l ly b l o c ks the b i nding  of 
p o lyme rase t o  t he TATA box the reby pre vent ing t r ansc r i p t i on 
i n i t i a t i o n [ 4 4 ]  I t  is unknown whe t h e r  o t h e r  fa c t o rs c a n  
ove r r i de t he effe cts o f  LBP-l b u t  neve r t h e l ess i t  con t r ibutes 
t o  v i ro l og i c a l  l a t ency . 
T h e  modu l a t o ry region d i c t a tes the  r a t e  a t  w h i c h  
t ra nsc r i p t i on occurs . I t  a lso cont a i ns sequ ences w h i c h  a r e  
t a rg e ts f o r  c e l l u l a r  factors . The b i nding  si tes o f  t h e  
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modu l a t o ry r e g i on i n c l ude a c t i vator prot e i n - l  ( AP-l ) , c h i c ken 
ova lbumi n up s t ream promo t e r  ( COU P )  , n u c l e a r  f a c t o r  o f  
a c t i va t e d  T c e l l s  ( N F-AT ) , upst ream s t imu l a t o ry factor  ( US F ) , T  
c e l l  fa c t o r- l  u ,  and nuc l e a r  factor kappa B ( N F-KB ) . N F-AT and 
N F-KB are of p a r t i c u l a r  importance because they are i nduced by 
a c t i  v a t i on o f  T h e l p e r  c e l l s . Re s t i n g  T c e l l s  h a v e  a n  
inhib i t o r  kappa B protein ( IKB ) wh ich i s  bound t o  cytop l a sm i c  
N F-KB . U p o n  a c t ivat ion o f  the  T ce l l ,  b y  a n t i gen or cyt o k i n e s  
s u ch a s  TN F-u , N F-KB d i s s o c i a t e s  from t h e  i n h i b i t o r  a n d  N F-KB 
i s  t ransported to the nuc l eus . Subsequent b i nd i ng of N F - kB t o  
i t s  b i nd i ng s i t e r e s u l t s  in  expre s s i on o f  ce l l u l a r  g e n e s  
i n c l u d i n g  I L - 2 R . N F-KB a l s o  binds to  the  r e g i o n  w i t h i n  t h e  
L T R  o f  i n t e g r a t e d  p r ov i r a l  DNA a n d  enhances  t ra n s c r i p t i on o f  
t h e  v i r u s . T h e  v i r u s  i s  a b l e  to  r e s t  i n  t h e  c e l l  unt i l  i t  
b e c ome s a c t i va t ed and beg i n s  repl i c a t i o n . The v a r i e ty o f  
s t imu l i  w h i c h  i nduce N f -KB a l s o  provide t he s i gn a l  r e qu i r e d  
f o r  r e a c t i va t i on o f  l a tent  i n f e c t ion . 
Al t e r n a t i ve l y ,  b i nding  to  the  U S F  r e s u l t s  i n  de c r e a s e d  
H I V  expre s s i on . T h i s  s e quence r e s i de s  i n  t h e  n e ga t i ve 
regu l a t o ry bi nding f a c t o r  b i nd i ng s i t e [ 4 5 )  De l e t i on s  o f  t h i s  
b i nd i n g  s i t e  r e s u l t  i n  i n c r e a s e d  expre s s i on o f  H I V  f u r t h e r  
s uppor t i ng i t s  r o l e  a s  a down regulator  o f  t ra n s c r i p t i on [ 4 6 ) . 
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B i nd i n g  s i t e s  f o r  A P - 1 ,  COU P ,  a n d  T - c e l l  f a c t o r - 1 a a r e  even 
f u r t h e r  u p s t ream . I n  a s i mi l a r  manne r ,  howeve r ,  de l e t i on o f  
t h i s  r e g i on r e s u l t s  in  i nc r e a s e d  expre s s i on sugge s t i n g  once 
again t h a t  these areas o f  the LTR may be part  o f  the nega t i ve 
r e g u l a t o ry s equence [ 4 7 ] . Al l o f  t h e s e  s i t e s  p r obably 
c on t r i b u t e  t o  ma i n t a i n i n g  provi r a l  l a t e n cy . 
The l a s t  r e g i on o f  the H I V  LTR i s  the TAR . Regu l a t i on i n  
t h i s  reg i on i s  d i c t a t e d ,  n o t  by c e l l u l a r  prot e i n s , b u t  b y  t h e  
v i r a l  prot e i n  TAT . Newly synthe s i zed TAR RNA forms a s t ab l e  
s t em l oop s t r u c t u r e  w h i c h  i s  t he n  a b l e  t o  b i nd TAT . 
Exp r e s s i on o f  TAT and i t s  b i nding  to  TAR r e s u l t s  i n  a n  
i n c r e a s e  i n  v i r a l  expres s i on [ 4 8 ] . Alt hough the  binding o f  TAT 
t o  TAR i s  e s s e n t i a l , c e l l u l a r  prot e i n s  a l s o a i d  in s e cu r i ng 
t h e  TAR s t em l oop by b i nd i ng to  i t . The a b s e n c e  o f  t h e s e  
p r o t e i n s  c a n  de c r e a s e  TAT induced t ra n s c r i p t i on . 
Along w i t h  t ra n s c r i p t i on a l  r e gu l a t i o n ,  H I V  h a s  a l s o  
deve l oped a me chan i sm o f  post  t ra n s c r i pt ional regula t i on . T h i s  
i s  i mp e r a t i ve s i nce t h e  v i r u s  ( wh i c h  i s  l e s s  t han 10 k b  i n  
lengt h )  expre s s e s  a t  l e a s t  n i ne di f fe rent genes r e s u l t i ng f r om 
ove r l app i n g  reading f rame s and a l t e r na t i ve s p l i c i n g . 
Fu r t h e rmo r e , the  r e l a t i ve amoun t s  o f  t h e s e  gene p roduc t s  
needed t o  p roduce a new v i r ion a r e  di f f e rent f o r  e a ch p r oduc t . 
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S tructure: 
The s t ructure o f  H I V  includes an inner nuclear core wh ich 
c on t a i n s  two cop i e s  o f  po s i  t i  ve po l a r i ty ,  s i ng l e  s t ra nded , 
s e n s e  v i r a l  RNA which i s  enclosed by a capsid  composed o f  gag 
e ncoded p r o t e i n s . The i nn e r  nuc l e a r  core i s  encomp a s sed by a n  
e n ve l op e  con s i s t i n g  o f  a l i p i d  b i l ayer i n  w h i c h  t h e  e n v  gene  
p r oduct gp 4 1  is  embedded . The o t h e r  ma j o r e n v  e n coded 
glycopro t e i n , gp1 2 0 ,  is  noncova l e n t ly as s o c i a t e d  with gp 4 1  and 
together  t hey make up t he ma j or envelope g lycop rot e i n ,  g p 1 6 0 . 
The s i g n i f i cance  o f  gp 1 2 0  i s  mu l t i f o l d . I t  d e t e rmi n e s  w h i c h  
c e l l s  become i n f e c t e d ,  p l ays a r o l e  i n  p a t hoge ne s i s  by 
i nd u c i n g  syncyt i um f o rma t i on ,  and i s  the  t a rget  of t h e rapie s 
a t temp t i n g  t o  i n t e rcept i n f e c t i on . 
C ell Tropism 
Gp 1 2 0  i s  t he receptor which med i a t e s  i n f e c t ion . I t  b i nd s  
t h e  C D 4  mo l e c u l e  on T h e l p e r  lymphocyt e s ,  ma c rophage s ,  and 
o t h e r  ce l l s  ( e .  g .  g l i a l  ce l l s ) . The i n f e c t i on o f  
monocyte s /ma c rophages  appe a r s  to  s e r ve a s  a r e s e rvoir  o f  v i r u s  
s i n c e  t h e s e  ce l l s  a r e  u s ua l ly not k i l led r a t h e r  t hey 
p e r s i s t [ 49 ]  Macrophages  may become in fected  a s  a r e s u l t  o f  
C D 4  b i n d i n g  o r  by i n t e rna l i z a t i on o f  v i r a l  immune c omp l e x e s  
w h i c h  b i nd f c  recept o r s . Once i n s i de , the  mac r ophage a c t i ng a s  
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an a n t i ge n  p r e s e n t i n g  c e l l  may proce s s  a n d  p r e s e n t  t h e  v i r u s  
i n  t h e  c o n t e x t  o f  MHC c l a s s  I I  to  C D 4 + T h e l p e r  c e l l s .  T h i s  
ce l l  t o  c e l l  i n t e r a c t i on between ma c roph a g e s  a n d  T ce l l s  may 
f a c i l i t a t e  t ran smi s s ion of the virus [ 5 0 ) . Ant i - C D 4  ant ibod i e s  
p revent i n fe c t i o n  o f  both  ma crophages  and T ce l l s . 
Al t hough the mac rophage pl ays a role in  H I V  pa t hogene s i s , 
t he p r ima ry h o s t  c e l l  i n f e c t e d  by H I V  i s  t h e  C D 4 + h e l p e r  T 
lymphocyt e .  I n  addi t i on ,  i t  i s  the  de s t ru c t i on o f  t h e  T 
lymphocyt e ,  n o t  t h e  M� , w h i c h  d i c t a t e s  t h e  c o u r s e  o f  d i s e a s e  
c a u s e d . T h e l p e r  lymphocy t e s  p l ay a cruc i a l  r o l e  i n  b o t h  
c e l l u l a r  and humo r a l  immune re spon s e s . They a re a b l e  t o  
i n t e r a c t  w i t h  a n t i gen presented in  t h e  context o f  MHC c l a s s  I I  
on B c e l l s  and o t h e r  ant i gen p r e s e n t i ng ce l l s . Upon 
a c t i v a t ion , t hey secrete cyt o k i n e s  which orche s t ra t e  t h e  r e s t  
o f  t h e  immune re spon s e . There fore , t he i r  de s t ru c t i on 
t h r oughout H I V  i n f e c t i on h a s  an  impact  on t h e  e n t ire immun e  
sys t em r e s u l t ing i n  s e v e r e  immunosuppre s s ion , AI DS , a n d  dea t h . 
The me chani sms o f  p a thogene s i s  o f  AI DS w i l l  be d i s c u s sed later  
i n  t h i s  s e c t i on . 
Syncytium formation 
I n  addi t i on to  med i a t ing i n fe c t i on , the  enve l ope prot e i n  
a l s o  h a s  t h e  abi l i ty to  i nduce syncytium forma t i on . T h e  gp 1 2 0  
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o n  t h e  s u r fa c e  o f  i n fe c t e d  ce l l s  can b i nd and f u s e  s e v e r a l  
u n i n f e c t e d  ce l l s  l e ading t o  the  forma t i on o f  a g i a n t  
mu l t i n u c l e a t e d  c e l l c a l l e d  a syncyt i a [ S l , S 2 ] . S ome syncy t i um 
cont a i n  up to  SOO nuc l e i . The c e l l  u s ua l ly d i e s  w i  t h i n  4 8  
hours a f t e r  forma t ion . T h i s  may account for the l a rge decrea s e  
i n  T c e l l s  e v e n  t hough very f e w  a r e  a c t u a l ly i n f e c t e d . 
A l t hough syncy t i um f o rma t i on i s  ra r e ly seen  i n  vi t ro, HIV 
i s o l a t ed d u r i n g  a c c e l e r a t ed pha s e s  o f  i n f e c t i on i n  v i vo have 
a g r e a t e r  capa c i ty t o  i nduce syncy t i um forma t i on i n  vi t ro . 
T h e s e  syncy t i um i n du c i ng i s o l a t e s  ( S I ) a r e  p r i ma r i ly T c e l l  
t ropi c whe r e a s  non- syncyt i um inducing ( NS I )  i s o l a te s ,  obt a ined 
e a r l i e r  i n  t h e  cou r s e  o f  i n f e c t i o n  a r e  be l i eved t o  be 
monocyte /ma c ropha g e  t ropic [ S 3 , S 4 ] 
G1ycoprotein 120 
T h e  i n t e r a c t i o n  o f  gp 1 2 0  w i t h  C D 4  h a s  been e x t en s i ve ly 
s t udied . Both have been mapped t o  mo re c l e a r ly unde r s t a nd t h e  
i n t e r a c t i o n  and mo re imp o r t a n t ly h o w  to  i n t e r f e r e  w i t h  i t  to 
p r e v e n t  i n f e c t i on or p a t h ogen i c  mecha n i sm s uch as syncy t i um 
f o rmat i o n . Gp 1 2 0  h a s  f i ve hype rva r i ab l e  doma i n s , Vl-VS, and 
fi  ve  c o n s e rved doma i n s , C l - C S . These r e g i o n s  are b rought  
together  by e x t en s i ve d i s u l f i de bonds . The c - t e rmi n a l  r e g i on 
o f  g p 1 2 0  con t a i n s  the  ma j or i ty o f  res idues which a r e  imp o r t a n t  
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f o r  C D 4  b i nding , i nc l uding C 2 , V3 , C 3 ,  V 4 , and C 4  [ 5 5- 5 7 ] . 
N e u t ra l i z i ng a n t ibod i e s  a r e  generated i n  r e spon s e  t o  H I V  
i n f e c t i on . The e p i t ope which r e s u l t  in  t h e  mo s t  e f f e c t i v e  
n e u t ra l i z a t i on and i n h i b i t ion o f  c e l l  f u s i on i s  l o c a t e d  w i t hi n  
t h e  t h i rd v a r i a b l e  doma i n - V 3 [ 5 8 ] . 
S tages of dis eas e: 
The cou r s e  o f  H I V  i n f e c t i on con s i s t s  o f  t h r e e  s t a g e s  
expe r i enced by mo s t  p a t i e n t s [ 5 9 ] . T h e  f i r s t  o r  a c u t e  s t a g e  
o c c u r s  f o l lowing p r ima r y  i n fe c t ion . T h e  immune s y s tem moun t s  
a d e t e c t a b l e  c e l l u l a r  and humo r a l  immune r e sp o n s e  w h i c h  
de s t roys t he v i r u s  in  the blood . Du r i ng t h i s  p e r i o d ,  p a t i e n t s  
e x p e r i ence  a s l i g h t  de c r e a s e  i n  T c e l l  numb e r s  but  t h e y  
u s u a l l y  r ema i n  above 7 0 0  ce l l s /mm3• T h i s  i s  f o l l owed b y  t h e  
s e cond s t a ge o f  d i s e a s e ,  c l i n i c a l  l a tency,  the average l en g t h  
o f  w h i c h  i s  t e n  ye a r s [ 6 0] D u r i n g  t h i s  p e r i o d ,  t h e r e  i s  a 
g r a d u a l  i n s i d i o u s  de c l i ne i n  T c e l l  number and funct i o n . T 
c e l l c o un t s  range f r om 7 0 0 - 2 0 0  c e l l s /mm3• As t h e  c e l l  numb e r  
d e c re a s e s ,  t h e  p a t i e nt  be come s mo re s u s cept i b l e  t o  i n f e c t i on 
a n d  b e g i n s  t o  expe r i ence c l i n i c a l  s ympt oms . F i na l l y ,  t he 
t h i rd s t a g e  deve l op s , AI DS ,  and death u s ua l l y  occurs  w i t h i n  a 
p e r i od o f  two yea r s  a f t e r  t h i s  s t a g e  begins . At  t h i s  s t a g e ,  
c e l l  c o un t s  f a l l  b e l ow 2 0 0  c e l l s /mm3• 
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The l o s s  o f  C 0 4 + T 
c e l l s  c a u s e s  widespread immunosupp re s s i on . T h i s  l e a d s  t o  
mu l t i p l e  oppo r t un i s t i c  i n f e c t i ons  w h i c h  t he p a t i e n t  c a n n o t  
c l e a r . 
The f i r s t  s tage o f  di s ea s e , te rmed acute H I V  s yndrome , i s  
a cc omp a n i e d  b y  c h a r a c t e r i s t i c  f l u  l i ke s ympt oms i n c l u d i n g  
f e ve r ,  l e t h a r g y ,  ma l a i s e , sore  t h roa t ,  mya l g i a s , and 
headache . T h i s  u s u a l l y  occurs  wi t h i n  t h r e e  t o  s i x  we e ks 
a f t e r  i n f e c t ion w i t h  H I V  al t hough everyone doe s not expe r i e n ce 
i t  t o  t h e  s ame de gree [ 6 1 - 6 3 ) . There a r e  h i g h  levels  o f  v i remi a 
w h i ch e l i c i t  both  a c e l l u l a r  and a h umo r a l  i mmune r e spon s e  
w i t h i n  o n e  we e k  t o  t h r e e  mon t h s [ 6 2 , 6 3 ) . A n  i n c r e a s e  i n  v i ru s  
s pe c i f i c  c y t o t ox i c T l ymphocytes  a n d  comp l eme n t  b i nd i n g  
a n t ibody a i d  i n  c l e a r i n g  the  v i r u s  f r om t h e  b l ood . T h e  
de c r e a s e  i n  v i remi a i s  a s s o c i a t ed w i t h  a l o s s  o f  c l i n i ca l  
s ympt oms a l t hough many pa t i e n t s  con t i nue t o  expe r i e n c e  
p e r s i s t e n t  gene r a l i z ed l ymphadenop a t h y . 
T h e  s e cond s t a ge i s  te rmed " c l i nical  l a t e n c y "  a nd l a s t s  
a n  a v e r a g e  o f  t e n  yea r s ,  s h o r t e r  for  the y o u n g  a nd 
e l d e r l y [ 5 9 ) . Al t hough mo s t  p a t i e n t s  a r e  c l i n i c a l l y  
a s ympt oma t i c  w i t h  n o  detectable vi remi a ,  t he v i r u s  i s  a c t i v e l y  
repl i c a t i ng i n  l ymphoid organs [ 6 4 ) . I t  i s  be l i eved t h a t  H I V  i s  
c a r r i ed t o  the  l ymph nodes i n  a s imi l a r  way a s  o t h e r  pathogens 
18 
and t r apped on f o l l i cu l a r  dendr i t i c  c e l l s  in  order t o  gene r a t e  
a spe c i f i c  h umo r a l  r e s pon s e . I f  s o ,  t h i s  e s t a b l i s h e s  a s i t e  
o f  con t inua l i n fe c t ion during c l i n i ca l  l a tency . Seve r a l  l i nes  
o f  evi dence s upport this  theory and wi l l  be f u r t h e r  d i s cus sed 
i n  t h e  me c h a n i sms o f  pa thogene s i s . At t h i s  t ime ,  t h e  
h i s t o l og y  o f  t h e  l ymph node i s  chara c t e r i z e d  by f o l l i cu l a r  
hyperp l a s i a  a n d  i n c r e a s e d  c e l l u l a r  i n f i l t r a t e . Du r i ng t h e  
l a t t e r  p a r t  o f  t h i s  s t age , t he sma l l  l ymphoc y t i c  i n f i l t r a t e  
f o rms a g g r e g a t e s  which r e s u l t  in  t h e  d i s rup t i on o f  f ol l i c l e s . 
The events  t h a t  occur du r i ng c l i n i c a l  la tency a r e  aggr e s s i ve l y  
b e i n g  r e s e a rched s i nce t h i s  i s  t h e  s t age o f  p r og r e s s i ve 
dep l e t i on o f  C D 4 + T ce l l s  and i t  i s  b e l i eved that  i n t e rven t i on 
a t  t h i s  t ime point wou l d  be mo s t  hope f u l . Recent r e s e a r c h  b y  
L a n e  e t . al .  ( unpub l i s h e d )  s ugge s t s  t h a t  once t h e  T ce l l  
r e pe r t o i r e  h a s  been de s t royed t h e r e  i s  n o  way o f  r e t r i ev i n g  
i t . Howeve r ,  e x i s t i ng T ce l l  c l ones  can be f o r c e d  t o  
p r o l i f e r a t e  when t re a t e d  w i t h  I L- 2 . Such  t h e r a p i e s  ma y d e l a y  
t h e  o n s e t  o f  A I DS . 
T h e  l a t t e r  s t age o f  d i s e a s e  i s  a s s o c i a t e d  w i t h  t h e  
reeme rgence o f  cl i n i c a l  s ymptoms a n d  severe immunode f i c i e ncy . 
C D 4 + T c e l l s  cont i nue t o  de c l i n e  u s u a l l y  a v e r a g i n g  b e l ow 2 0 0  
c e l l s /mm3• The l ymph node i s  c h a r a c t e r i z e d  b y  a de c r e a s e  i n  
FDC numbe r [ 6 5 )  and a n  i n f l u x  i n  C D 8 +  T ce l l s ,  a c e l l  norma l l y 
not found i n  t h e  g e rminal  center  i n  h i g h  numbe r s . 
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T h e  l ymph 
node a rc h i t e c t u r e  i s  di s rupted as the f o l l i c l e  invo l u t e s  and 
the  FOC r e t i cu l um i s  l o s t . There i s  a subs equent decrea s e  in 
v i r a l  RNA w i t h i n  the  g e rminal  center [ 6 6 ] . H I V  i s  a g a i n  a b l e  
t o  c i r c u l a t e  i n  t h e  b l ood [ 6 2 ]  . I t  i s  not known we t h e r  t h e  
i n c r e a s e  i n  v i r a l  load i s  d u e  to  an increase  i n  rep l i c a t i on o r  
a r e l e a s e  o f  t r apped v i r i ons f r om the l ymph node . P a t i e n t s  i n  
t h i s  s t a g e  o f  d i s e a s e  a re i n  a s t a t e  o f  s e v e r e  
immunosuppr e s s i on a s  a r e s u l t  o f  the  l o s s  o f  T l ymphocyt e s ,  a 
l o s s  o f  g e rmi n a l  cent e r s ,  and t h e  con t i n u a l  s t a t e  o f  h i g h  
i n f e c t i on caused by c i rculat ing H I V . They expe r i ence mu l t i p l e  
oppo r t un i s t i c  i n fe c t ions  and neop l a sms which u l t ima t e l y  l eads 
t o  de a t h [ 5 9 ] . 
Mechanisms of pathology 
T h e  immunosupp re s s i on a s s o c i a t ed w i t h  H I V  i n f e c t i on i s  
d i r e c t l y  c o r r e l a t e d  w i t h  C 0 4  + T l ymphocyte  dep l e t i on a n d  
dys funct i on . T h e  e x a c t  me c h a n i sm caus i ng t h i s ,  howe ve r ,  i s  
un known . Seve r a l  poten t i a l  me chani sms have been hypot he s i z e d ,  
s ome d i r e c t l y  r e l a t e d  t o  H I V  i n fe c t i on ,  o t h e r s  b a s ed on a 
de l e t e r i ou s  immune re sponse . E a ch o f  t h e s e  w i l l  be d i s cu s s ed 
b e l ow . 
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HIV Related Mechanisms 
H I V  r e l a t ed c e l l  k i l l i ng can occur t h roughout t h e  v i r a l  
l i fe c yc l e . A f t e r  i n fe c t i on w i t h  H I V ,  t h e  v i r u s  p r odu c e s  
e n ve l ope p r o t e i n s , gp 4 1  and g p 1 2 0 ,  and i n s e r t s  t hem i n t o  t h e  
t a r g e t  c e l l ' s p l a sma membrane . I t  has  been p ropo sed t h a t  t h i s  
c o u l d  r e s u l t  i n  i o n  f l ux e s  l e ading t o  c e l l  d e a t h . T h e  
e n v e l ope p r o t e i n  gp 1 2 0  a l s o  cont r i b u t e s  t o  me c h a n i sms o f  
di r e c t  k i l l i ng b y  inducing s yncyt i um forma t i on . I n  v i t r o ,  
s yn c y t i um f o rma t i on h a s  been corr e l a t ed w i t h  t h e  c y t opa t h i c  
e f f e c t s  o f  H I V  o n  i n fected cel l s [ 6 7 ] . T h i s  mechani sm d i s cu s s e d  
e a r l i e r  i nvolves  f u s i on o f  i n fe c t e d  ce l l s  w i t h  u n i n f e c t e d  
c e l l s  t h rough t h e  g p  12 0 - C D 4  
mo l e c u l e s [ 6 7 , 6 8 ]  
i n t e r a c t i on and L FA- 1 
Ano t h e r  di r e c t  me ch a n i sm o f  t a rg e t  ce l l  k i l li n g  i s  
r e l a t ed t o  unintegra ted prov i ru s . Accumula tion o f  unin t e g r a t e d  
provi r a l  DNA i s  t hought t o  k i l l  the  c e l l  o r  prevent  no rma l 
ce l l u l a r  p r ot e i n  s yn t he s i s  t h u s  rende r i ng 
non funct i on a l  [ 6 9 ]  . A fourth proposed me chan i sm 
t h e  c e l l  
po s t u l a t e s  
t h a t  i n t r a ce l l u l a r  b i nding  o f  C D 4  t o  gp 1 2 0  l e a d s  t o  t he s e  
c omp l e x e s  be coming l odged in  nucle ar pores i n t e r rupt i ng norma l 
t r a f f i c k i n g  o f  mRNA f r om the n u c l e u s  t o  t h e  c y t op l a sm . 
F i na l l y ,  a s  the  v i r u s  progeny buds f r om t h e  h o s t  c e l l , t h e  
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membr a n e  may b e  dama ged u l t ima t e l y  k i l l i ng t h e  c e l l . 
I n  a dd i t i on to  the  qua n t i t a t i ve l o s s  o f  C D 4  + T ce l l s ,  
H I V  i n f e c t i on a l s o  c a u s e s  l o s s  o f  T ce l l  fun c t i on b y  a va r i e t y  
o f  me c h a n i sms [701 .  Fi r s t , H I V  i n f e c t i on r e s u l t s  i n  abnorma l 
r e s p on s e s  t o  s o l u b l e  a n t i gen and de f e c t s  i n  p r o l i f e r a t i o n . 
S e cond , i n  vi t ro studi e s  have demon s t r ated H I V  induced T cell 
,anergy . Expo s u re o f  c e l l s  to  enve l ope prot e i n s  gp1 2 0  and gp 4 1  
a n d  c o r e  p r o t e i n  p 2 4  r e s u l t e d  i n  i n h i b i tion o f  T ce l l  
re spon s e s  when cha l l enged w i t h  another a n t i gen . F i na l l y ,  t h e  
b i nd i n g  o f  gp 1 2 0  t o  C D 4  m a y  prevent norma l a n t i ge n  
p r e s e n t a t i on t h rough M H C  c l a s s  I I  a n d  m a y  p r e v e n t  norma l 
s i g n a l i n g  r e qu i re d  t o  e l i c i t  a r e spon s e . Re g a r d l e s s  o f  t h e  
c a u s e , l o s s  o f  T c e l l  function  cont r i b u t e s  to  immune 
s uppre s s i on experi enced i n  l a te  H I V  i n f e c tion and A I DS . 
Immunopathogenic Mechanisms 
T h e  rema i n i n g  immunop a t hogen i c  me chani sms a re n o t  
di r e c t l y  r e l a ted to  H I V  i n f e c t i o n ,  but to  d e l e t e r i o u s  f e a t u r e s  
o f  the  normal immune response . Some o f  t h e s e  f e a t u r e s  r e s u l t  
i n  t h e  ma i ntenance  a n d  a ugmen t a t i on o f  H I V  i n f e c t i o n  wh i l e  
o t h e r s  c a n  b e  d i r e ct l y  cytopa t h i c  to  t a rg e t  c e l l s . 
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Cytokines 
The immune s y s t em i s  dependent on a netwo r k  o f  c y t o k i n e s  
t o  o r c h e s t ra t e  immune re sponse s .  Howeve r ,  s e ve r a l  c y t o k i n e s  
h a ve b e e n  imp l i ca t e d  i n  a c t i v a t i ng H I V  expre s s i on f rom 
l a te n t l y  i n fe c t ed ce l l s . TN F-u ,  for  examp l e ,  h a s  been s h own 
t o  i n c r e a s e  H I V  repl i c a t i on when i t  induce s N F-KB 
produ c t i on [ 7 1 ]  I n  add i t i o n ,  I L - 6  and granulocyte ma c r ophage 
s t imul a t ing factor ( GM-CS F )  have been shown to  incre a s e  v i r a l  
r ep l i c a t i on i n  mac ropha ges and t h i s  me cha n i sm i s  p r ima r i l y  a t  
t h e  p o s t t r a n s c r i p t i onal  l e ve l . Fu r t h e rmore , TN F-u c a n  a c t  
s yn e r g i s t i ca l l y  w i t h  e i t h e r  I L- 6  or GM- C S F  t o  i n c r e a s e  H I V  
repl i c a t i on . Other  cytokines  impl i cated s i mi l a r l y  i n c l ude I L-
1 ,  I L- 3 ,  T N F- � , I N F-y, and M - C S F [ 7 1 , 7 2 ] . T h e  n e t wo r k  o f  
c y t o k i n e s  m a y  c o n t r i b u t e  t o  s u s t a i n ing v i r a l  exp r e s s i o n  even 
i n  t ime s o f  appa rent  l a tency . 
Germinal C enter Responses 
I n  t h e  l a t e  1 9 8 0 ' s  s e v e r a l  g roups made t h e  ob s e r va t i on 
t h a t  H I V  i n  t h e  l ymph node s during  c l i n i c a l  l a t e n c y  w a s  
a s s o c i a te d  w i t h  h i s t o l o g i c  c h a n g e s  i n c l u d i n g  f o l l i cu l a r  
hype rp l a s i a  a n d  expan s i on o f  t h e  FDC netwo r k [ 7 3 - 7 6 ] . Recent  
s tudi e s  h ave now focused on s e conda ry l ympho i d  t i s s u e  and i t s  
r o l e  i n  H I V  immunopathogene s i s . 
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One current  h ypo t he s i s  
s u g g e s t s  t h a t  the  g e rminal  cen t e r  s e rves a s  a r e s e r v o i r  o f  
v i r u s  a n d  a s  s u c h  ma i n t a i n s  v i r a l  i n f e c t i on t h roughout 
c l i n i c a l  l a tency for  several  yea r s . After  i n f e c t ion , the  hos t 
moun t s  a n  immune re sponse which re s u l t s  i n  immune e l imina t i on 
o f  v i r u s  f r om t h e  b l ood . T h i s  response  r e s u l t s  i n  t h e  
gene r a t i on o f  a n t i body w h i c h  comp l e x e s  w i t h  t h e  v i r u s  w h i c h  
t he n  i s  t ransported to  t h e  neare s t  l ymph node whe r e  i t  wi l l  be 
t r apped on FOC . Al t hough t h i s  proc e s s  is normal and impo r t a n t  
i n  gene r a t i n g  and ma i n t a i n i n g  humoral  immune re spon s e s , i n  H I V  
i n f e c t i o n ,  i t  r e s u l t s  i n  s e eding mu l t i p l e  l ymph nodes w i t h  
i n fe c t ious  H I V  immune complexes  a n d  a l s o  provides a r e s e rvo i r  
o f  v i r u s . W i t h i n  t he g e rminal  c e n t e r  m i c roenvi r onme n t , 
a c t i va t e d  C 0 4 + T c e l l s - e s s e n t i a l  f o r  memo r y  a n t ibody 
re spons e s - r e s ide . S i nce t h e s e  c e l l s  a r e  act i va t ed they  may be 
ea s i l y  i n fected by virus t rapped on the FOC . Fu r t h e rmore , t h e y  
ma y s e rve a s  a c o n t i n u a l  source  o f  v i r u s  a s  t h e y  d i v i de a n d  
rep l i ca t e  t h e  integra ted provi r u s . B c e l l s  in  the  envi r onment 
ma y f u r t h e r  p r opa g a t e  HIV i n fe c t i on by r e l e a s i ng TN F-u . 
Several l i nes o f  evidence support the hypothes i s  t h a t  H I V  
i n  t h e  l ymph o i d  o r g a n s  cont ribut e s  t o  the  p a t h oge n i c i t y  o f  
A I OS . F o r  examp l e ,  Pant e l e o  e t .  al . compared the  v i r a l  burden 
in C 0 4 + T ce l l s  in p e r i p h e r a l  b l ood t o  that o f  l ymp h o i d  
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o rgans  ( 7 7 ) . He  demo n s t r a t e d  that t he fre quency of i n f e c t e d  
c e l l s  w a s  s u b s t a n t i a l l y  h i g h e r  in  l ymph o i d  t i s s ue when 
a s s a y i n g  f o r  p r ovi r a l  DNA . I n  addi t i on ,  h i gh l e ve l s  o f  H I V  
RNA were de t e c t e d  i n  l ymphoid t i s s ue b u t  not i n  p e r i ph e r a l  
bl ood samp l e s . L a t e r  t h e s e  h i gh conc ent r a t i on s  o f  v i ru s  w e r e  
f o u n d  t o  be a c t i ve l y  repl i c a t i ng wi t h i n  t he t i s s u e ( 6 4 ) . T h i s 
s uppo r t s t h e  hypot he s i s  t h a t  the  l ymph node s e rv e s  a s  a 
r e s e r vo i r  o f  v i r u s  and cont r i b u t e s  t o  the  dep l e t i on o f  C D 4  + 
T l ymphocyt e s . 
An i ma l s t ud i e s  a l s o  support t h i s  h ypo t h e s i s . U s i n g  t h e  
S I V  mod e l  o f  a c u t e  i n f e c t i on Pant e l eo e t . al. demo n s t r a t e d  
l o c a l i z a t i on o f  v i r u s  n o t  o n l y  w i t h i n  g e rmi n a l  c e n t e r s  o f  
s e conda r y  l ymph o i d  t i s s ue b u t  t rapped o n  t h e  proce s s e s  o f  
F DC ( 7 8 ) . L ymph node b i op s i e s  w e r e  p e r f o rmed a t  t h r e e  t ime 
p o i n t s  p o s t  i n fe c t i on w i th S I V . A f t e r  2 6  days , t h e  v i r u s  w a s  
l o ca l i z e d  i n  the  germi n a l  cent e r s . Fu r t h e rmore , i t  w a s  found 
t o  be c omp l exed w i t h  comp l ement and a n t ibody and held 
e x t r a ce l l u l a r l y  on the  F DC . U s ing t h i s  s ame mode l ,  t h e y  
e x amined t h e  event s l eading  up t o  H I V  l o ca l i z a t i o n  o n  
FDC ( f i gu r e  1 )  ( 4 8 ) . 
T h i s  corre l a t e s  w i t h  that  which i s  ob se rved i n  t h e  huma n 
r e s pon s e . Soon a f t e r  i n f e c t i o n ,  t h e r e  i s  an  i n c r e a s e  i n  
comp l emen t  b i nding ant ibod i e s . T h i s  i s  a s s o c i a ted w i t h  v i r u s  
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2 6  
t r apping  i n  t h e  FOC network [ 7 8 ) . Other  humo r a l  r e s p on s e s  
f o l l ow i n c l ud i ng t h e  gene r a t i on o f  neu t r a l i z i n g  ant ibod i e s  and 
t h e s e  a l s o  cont r i bute t o  immune comp l e x  f o rma tion and 
t r ap p i n g . T h e s e  norma l immune respon s e s  w h i c h  a t t empt s  t o  
d e s t roy t h e  v i r u s  appea r s  t o  b e  d e t r ime ntal  by loca l i z i n g  t he 
v i r u s  t o  a s i t e where i t  w i l l  not i n t e r a c t  w i t h  a l l  a rms o f  
t h e  immune response which a t t empt to  d e s t roy i t . I n s tead t h e  
v i r u s  h a s  e s t abl i shed a r e s e r vo i r  for  f u r t h e r  i n f e c t i on . 
Cytopathic mechanisms :  
T h e  dep l e t i o n  o f  C 0 4 +  T l ymphocyt e s  h a s  a l s o r e c e n t l y  
been l i n ked w i t h  apop t o s i s ,  o r  programmed ce l l  de a t h [ 7 9 - 8 2 ) . 
C 0 4 + T c e l l s  norma l l y  i n t e r a c t  w i t h  a n t i gen i n  the  cont e x t  o f  
MHC c l a s s  I I . T h i s i n t e r a c t ion r e s u l t s  i n  o n e  o f  t w o  s i g na l s  
r e qu i red for  apoptos i s . A f t e r  receiving the  second s i gna l ,  the  
ce l l  d i e s . This  me chan i sm ensures  that  a f t e r  a c e l l  has  been  
a c t i  v a t e d  and p e r forms its  e f fe c t o r  fun c t i on s , i t  w i l l  be 
e l iminated . I n  t h i s  manner , c e l l  and t i s s u e  dama ge is  t i g h t l y  
c o n t ro l l e d . I n  H I V  i n f ected i nd i v i du a l s ,  gp 1 2 0  on t h e  
s u r f a c e  o f  an  i n fe c t e d  c e l l  o r  g p  1 2 0  ant i - gp 1 2 0  immun e  
comp l e x e s  can b i nd t o  C O  4 on an  uninfected ce l l . Cros s l i n k i n g  
t h i s  r e ceptor  b e f o r e  the  T C R  i s  t r i ggered p r o v i d e s  a s i g n a l  
i nd u c i n g  apoptos i s . 
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Anot her norma l immune function which may prove t o  b e  both 
bene f i c i a l  and de l e t e r i ou s  is the  produ c t i o n  o f  HIV spe c i f i c  
a n t i bodi e s . An t i bodi e s ,  s ome o f  which a r e  neu t r a l i z i n g ,  a re 
p rodu ced a g a i n s t  s e v e r a l  prot e i n s  i nc l uding gp 1 2 0 . I n f e c t ed 
ce l l s  expre s s i ng gp 1 2 0  on i t s  s u r f a c e  w i l l  b i nd a n t ibody . 
Bi nding o f  t h i s  comp l ex to  natural  k i l l e r  c e l l s  wi l l  r e s u l t  i n  
a n t ibody dependent c e l l u l a r  c yt o t o x i c i t y . I n  an  a t t emp t t o  
r i d  t h e  body o f  v i r u s  t houg h ,  C 0 4  T c e l l  dep l e t i on ma y a l s o 
occu r . 
An o t h e r  a s p e c t  o f  the  immune response  t h a t  ma y a l s o be 
de l e t e r i ou s  i n  HIV i n fe c t i on r e l a t e s  t o  the  gene r a t i on o f  C 0 8 +  
T ce l l s . A l t h ough during  the  i n i t i a l  r e spon s e  t h e s e  c e l l s  
h e l p  t o  e l imi n a t e  the  p l a sma v i r a l  l o a d ,  du r i ng c l i n i ca l  
l a t e n c y  t h e y  a r e  seen  mi g r a t ing i n t o  the  ge rmi nal cen t e r ,  
where t h e y  a r e  norma l l y  not found i n  h i gh l e ve l s . T h i s ma y 
r e s u l  t i n  t h e  de s t r u c t i o n  o f  o t h e r  ce l l s  i n  t h e  ge rmi n a l  
cent e r  i n c l uding  h e l p e r  T c e l l s .  Fina l l y ,  d e s t r u c t i on o f  t h e  
F O C  n e t wo r k  m a y  re s u lt i n  immune suppr e s s i on o f  ma ny B c e l l  
r e s p on s e s  i n c l uding  memory . 
We b e l i e ve that  there i s  s t rong evidence that  H I V  i n  the  
l ymph node i s  a ma j o r cont r i b u t o r  t o  pat hogene s i s . T h i s  i s  
t h e  p r ima r y  s i t e  o f  i n f e c t i on t h roughout c l i n i ca l  l a t e nc y . 
Fu r t h e rmore , f u l l  b l own A I DS i s  a ccomp a n i e d  by di s rup t i on o f  
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t he l ymph node a n d  t h e  FOC r e t i c u l um .  There f o r e , t h e  
rema i nde r o f  t h i s  b a c k g round s e c t i on w i l l  focus  on  t h e  
ge rmi n a l  c e n t e r s  i n  t he lymph node , t he f o l l i c u l a r  dend r i t i c  
c e l l , a n d  t h e  u n i que microenvi ronme n t  they provide wh i c h  i s  
condu c i v e  t o  H I V  i n fe c t i on . 
Germinal Centers and FOC 
Lymp h o i d  f o l l i c l e s  a r e  found i n  t h e  B ce l l  dependent 
a r e a s  o f  s e conda ry lymphoid t i s s u e , i n c l ud i n g  l ymph node s , 
t o n s i l s ,  and s p l e e n . They a r e  composed o f  B ce l l s ,  T c e l l s , 
macrophage s ,  and fol l i c u l a r  dendr i t i c  cel l s  ( FOC ) 7 [ 8 3 ] . They 
can  be f u r t h e r  c l a s s i f i e d  i n t o  p r ima ry or s econdary f o l l i c l e s  
based o n  t he i r  s t a t e  o f  a c t i va t i on . P r ima ry f o l l i c l e s  c on s i s t  
mo s t ly o f  r e c i r c u l a t i ng B lymphocytes w i t h  approxima t e l y  5 %  T 
lymphocyte s ,  mo s t  o f  which a r e  C 04 + .  These  cel l s  pa s s  t h rough 
a r e t i cu l um o r  c e l l u l a r  network f o rmed by FOC . P r imary 
f o l l i c l e s  become s e condary f o l l i c l e s  when ge rmi n a l  c en t e r s  
form upon a n t i g e n i c  cha l l enge . These  s i t e s  a r e  char a c t e r i zed 
by f o c i  o f  rapidly p ro l i f e r a t i ng B ce l l s  and s ome T ce l l s  
s u r rounding  a n t i g e n  be a r i n g  F OC . The g e rmi n a l  c e n t e r  
repre s e n t s  a mic roenvi ronme n t  w h i c h  fa c i l i t a t e s  t h e  
i n t e ra c t i o n  o f  ce l l s  r e s u l t i n g  i n  the  produ c t i on a n d  
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ma i n t e na n c e  o f  memo r y  humo r a l  respon s e s . T h e s e  a r e a s  a re 
a s s o c i a t ed w i t h  c l on a l  expa n s ion o f  B c e l l s [ 8 4 -8 6 ] , s oma t i c  
mu t a t i o n [ 85 -88 ] , and s e l e c t i on o f  a n t i gen s pe c i f i c  B c e l l  
c l o n e s  [ 8 9 ] . The g e rm i n a l  cent e r  i s  a l s o  a s s o c i a t e d  w i t h  t h e  
ma i n t en a n c e  o f  
di f f e r e n t i a t i on 
ce l l s  [ 9 2 - 9 4 ] . 
the  
of  
humo r a l  
memor y  B 
response by i n duc i n g  t h e  
ce l l s  [ 9 0 ,  9 1 ]  a nd p l a sma 
S e condary  l ymph o i d  f o l l i c l e s  can be d i v i de d  i n t o  t h r e e  
di f fe r e n t  r e g i ons  by l i ght micros copy . The f i r s t  o f  t he s e ,  t h e  
f o l l i cu l a r  ma n t l e  f o rms on t h e  o u t e r  edge o f  t he f o l l i c l e . 
T h i s  r e g ion con s i s t s  p r ima r i l y  o f  r e c i r c ul a t i ng B ce l l s . The 
s e cond a n d  t h i rd regions a r e  the  l i g h t  and da r k  zone s . T h e  
g e rmi n a l c en t e r ,  which  i s  l oc a t e d  bene a t h  t h e  f o l l i cu l a r  
mant l e ,  i s  f ound i n  t h e s e  two regions . The light r e g i on , which  
is  a d j a c e n t  t o  t h e  ma n t l e ,  is  heavily  i n f i l t r a t e d  b y  t h e  FOC  
netwo r k . M o s t  o f  the c e l l s  i n  this  a rea  a r e  not p r o l i fe r a t i ng 
a n d  do not  s t a i n  i n t en s e l y ,  t h u s  t h e  name l i g h t  z on e . 
Adj a c e n t  t o  the  l i ght zone i s  the dark  zone , named because  i t  
h a s  a much den s e r  popu l a t ion o f  h i g h l y  a c t i v a t e d ,  r a pi d l y  
prol i fe r a t i ng l ymphocytes which s t a i n  i nt e n s e l y .  Fu r t h e rmore , 
t i n g i b l e  body ma c r ophages  a r e  found h e r e . T h i s  a r e a , b e i n g  
t h e  f a r t h e s t  f rom t h e  f ol l i c u l a r  mant l e , i s  i n f i l t r a t e d  o n l y  
w i t h  t h e  f i ne dendr i t i c  proce s s e s  o f  the  F O C  n e t wo r k .  
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Follicular Dendritic C ells 
Fol l i cular  dendr i t i c  ce l l s  were d i s covered by Nos s a l  
e t . al . [ 9 5 ]  and S z a ka l  & H a n n a  [ 9 6 ]  i n  1 9 68 .  T h i s  ce l l ,  
wh i c h  i s  fundame n t a l  t o  g e rminal  c e n t e r  devel opme n t  and t h e  
immune r e s pon s e s  t h a t  o c c u r  there , has  three ca rdin a l  f e a t u r e s  
d i s t i n gu i s h i n g  i t  from o t h e r  dendr i t i c  ce l l s . F i r s t ,  FOC a r e  
norma l l y  f ound on l y  w i t h i n  t h e  fol l i c l e s  o f  s e conda r y  l ymph o i d  
t i s s ue a l t hough i n  pa t h o l og i c a l  s t a t e s  t h e y  can  be found 
e l s ew h e r e  ( e . g .  rheuma t o i d  nodu l e s ) .  S e cond , t h e y  h a ve a 
cha r a c t e r i s t i c  dend r i t i c  mo rphology w i t h  l ong , h i g h l y  
convo l u t e d ,  dendr i t i c  proce s s e s  ema n a t i ng from the  c e l l  body 
and f i na l l y ,  t h e i r  mos t  important feature is t h e i r  abi l i t y  to 
t rap and r e t a i n  a n t i gen in the f o rm of immune comp l ex e s  on 
t he i r  s u r face for several  months  to seve r a l  yea r s [ 97 ]  Along 
h i g h l y  w i t h  t h e  c a rdi n a l  f e a t u re s ,  t h e  l i t e r a t u re i s  
con s i s t e n t  o n  t h e  l a c k  o f  phagocyt i c  a c t i v i t y  o r  a n y  o t h e r  
i n t e rna l i z a t i o n  proce s s ,  i r regul a r l y  s h aped e u c h r oma t i c  
n u c l eu s ,  c omp l eme n t  recept o r s , and adhe s i on mo l e c u l e s  
i n c l ud i n g  I CAM- 1 a nd VCAM - 1  [ 9 2 , 9 7 - 1 0 5 ]  Fu r t h e r  a n a l ys i s  o f  
s u r f ace ma r ke r s  h a s  s hown that  FOC l a c k  the  c l a s s i ca l  ma r k e r s  
f o r  T c e l l s: C 08 a n d  Thy - 1 ;  8 c e l l s : 82 2 0 ;  ma c rophage s: M a c  
1 , 2 , 3 ; a nd NK ce l l s : NKH - 1 [ 98 , 9 9 , 1 0 3 , 1 0 6 - 1 1 0 ] . Re s e a r ch e r s  
a re di vided on the  expres s i on o r  l a c k  o f  exp re s s i on f o r  o t h e r  
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s u r fa c e  ma r ke r s  i n c l uding MHC c l a s s  I I ,  Fe gamma recept o r s , Fe 
eps i l on r e c ep t o r s , l e u cocyte common a n t i g e n ,  S - 1 0 0  p r ot e i n ,  
C 0 4 , C 0 1 4 , C 0 1 9 ,  C 02 0 ,  C 02 1 ,  and C 0 4 S [ 98 , 9 9 , 1 0 2 - 1 1 2 ) . T h i s  
i nc on s i s t e n cy may be due t o  t h e  h e t e rogene i ty o f  FOC a nd may 
be f u r t h e r  comp l i ca t e d  by the s t a t e  of a c t i v a t i on of t h e  
c e l l  [ 9 9 ,  1 0 5 )  . 
The expre s s i on o f  various  molecules  on the s u r face o f  FOC 
f a c i l i t a t e s  t h e i r  i n t e r a c t i on w i t h  B and T lymphocyt e s . FOC 
w h i c h  expr e s s  I CAM- 1  and VCAM- 1 i n t e r a c t  w i t h  adhe s i on 
mo l e c u l e s  L FA- 1 a nd VLA- 4 ,  respe c t i ve l y  on  B and T ce l l s . 
These  adhe s i ve i nt e ract ions  a i d  i n  s e c u r i ng t he c e l l s  and p l ay 
a n  impo r t a n t  role  i n  the re spon s e s  that  occur i n  t he g e rmi n a l  
c e n t e r . Monoc l o n a l  a n t ibod i e s  YN 1 / 1 . 7 [ l 1 3 , 1 1 4 )  o r  M K 1  
[ l 1 S ,  1 1 6 )  w h i c h  b l o c k  i n t r a ce l l u l a r  adhe s i on mo l e c u l e s , 
prevent FOC -B c e l l  c l u s t e r i n g  and B c e l l  prol i fe r a t i on . I CAM 
on FOC may provide a s e cond s i gnal  to a c t i va t e  B c e l l s  w i t h i n  
t h e  g e rmi n a l  c e n t e r . T l ymphocyt e s  have s imi l a r  adhe s i on 
mo l e c u l e s  a nd a r e  a l s o b e l i eved t o  i n t e r a c t  w i t h  FOC . 
FOC a r e  a l s o be l i eved t o  have i n t e ra c t i on s  wh i c h  a i d  i n  
s p a r i n g  ce l l s  f rom apopt o s i s ( 9 9 ) . 
known t o  s t imu l a t e  B cel l s [ l 1 7 ) . 
FOC expr e s s  C O  2 3  whi ch i s  
I n  add i t i on , FOC expr e s s  C O  
4 0  whi ch i n t e r a c t s  w i t h  i t s  l i gand o n  T ce l l s . B ce l l s  a l s o 
e xp r e s s  C O  4 0 .  T h e s e  i n t e ra c t i on s  may con t r i bute  t o  a 
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m i c r o e n v i r onme n t  w h i c h  decrea s e s  apopt o s i s  and f a c i l i t a t e s  
ge rmi n a l  c e n t e r  B c e l l responses [ 9 9 ] . 
FOC and the Germinal Center Resp ons e 
T h e  immu n o l o g i c  eve n t s  t h a t  occur i n  the  g e rm i n a l  
c e n t e r  a re n o t  f ound a t  a n y  o t h e r  s i t e  i n  t h e  body . I t  u s ua l l y 
t a ke s  a f e w  mic rog rams o f  a n t i gen t o  e l i c i t  a s e conda r y  
response  y e t  FOC r e t a i n  o n l y  1 0 0 - 5 0 0  pi cog rams / node a n d  t h i s  
ma i n t a i n s  potent  memor y [ 1 18 ]  T h e  abi l i t y  t o  g e n e r a t e  t h i s  
t ype o f  r e s pon s e  w i t h  on l y  l ow l e ve l s  o f  a n t i ge n  depends o n  
a l l  o f  t h e  ce l l s  t h a t  con t r ibute  t o  t h e  dynami c 
microenvi ronmen t  o f  t he germi n a l  cent e r . FOC a r e  be l i eved t o  
p l a y a c r i t i ca l  r o l e  i n  the  ge rmi n a l  center  r e a c t ion a n d  when 
they a re de c r e a s ed i n  number o r  a b e r r an t ,  ma r ked a l t e r a t i on s  
i n  g e rmi n a l  c e n t e r  s i z e  a n d  n umb e r  occur [ 1 1 9 ] . 
T h e  even t s  l e a d i n g  t o  a s e conda ry r e s p o n s e  and t he r o l e  
o f  t h e  g e rmi n a l  cen t e r  h a ve b e e n  c h a r a c t e r i z e d . A f t e r  
i n j e c t i on o f  a n t i g e n ,  immune complexes  a r e  rapidl y f o rmed and 
mos t  a r e  c l e a red by macrophages within  2 4 - 7 2  hours . We r e f e r  
t o  t h i s  me t hod o f  a n t i g e n  h a n d l i n g  a s  t he c l a s s i c a l  a n t i g e n  
p a t h w a y [ 1 2 0 ]  . S ome immune comp l e xe s ,  howeve r ,  e n t e r  t h e  
a l t e r n a t e  t ra n sport  p a t hway and a r e  t r ansported b y  a v a r i e t y  
o f  non-phagocyt i c  c e l l s  w i t h  dendr i t i c  mo rpho l o g y  t o  t h e  
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lymphoid fol l i c l e s [ 1 2 0 ] . These a n t i gen t ransport ce l l s  ( ATC ) 
a r e  s imi l a r  t o  FOC [ 1 2 0 ]  and may even be FOC p r e c u r s o r s . As 
t h e s e  ATC near t h e  l i ght zone o f  the  g e rminal  c e n t e r  t hey 
bec ome c on t i nuous  w i t h  the FOC r e t i cu l um .  
W i t h i n  t he ge rmi n a l  cen t e r , imma ture  f i l i form FOC r e t a i n  
immune c omp l e x e s  on t he i r  convo l u t ed dendri t i c  proce s s e s [ 1 2 1 ] . 
As t hey ma t u r e , s ome FOC appea r t o  have beaded dendr i t e s . 
T h e s e  b e a de d  dendr i t e s  i n t e r a c t  w i t h  the  proce s s e s  o f  o t h e r  
F O C  t o  f o rm immune comp l e x  c o a t e d  bod i e s , o r  I CCOSOMES [ 1 2 1 ] . 
I CCOSOMES c a n  b e  r e l ea s e d  i n t o  t h e  g e rmi n a l  c e n t e r  
m i c r o e n v i r onme n t  a n d  a r e  t h e r e f o r e  t hought t o  p l ay a n  
i mp o r t a n t  r o l e  i n  t h e  a l t e r na t i ve t r an s p o r t  p a t hway . T h e s e  
h i gh l y  immu n o g e n i c  i cc o s ome s a r e  e a s i ly e ndocyt o s e d  by 
n e i ghbo r i n g  B c e l l s . The a n t i gen i s  t hen proce s s ed by t h e  B 
cel l s  and p r e s e n t e d  i n  t he context o f  MHC c l a s s  I I  t o  a n t i gen 
speci f i c  T ce l l s . This  now a l l ows a T c e l l  spe c i f i c  response 
i n  t h e  f o rm o f  cyt o k i ne s e c r e t i ons  [ 1 2 2 ]  . T h u s , t h e  
a l t e rn a t i ve t ra n sport  p a t hway i s  b e l ieved t o  p l ay a r o l e  i n  
germi n a l  c e n t e r  forma t i on ,  B c e l l  pro l i f e r a t i o n ,  and memo ry B 
p r odu c t i o n [ 1 2 2 , 1 2 3 ] . 
T h e  con s equences  o f  t h e  ge rmi n a l  c e n t e r  r e a c t i on c a n  be 
d i  v i de d  i nt o  two pha s e s - a n t i body produ c t i on a nd memory B 
p r odu c t i on [ 9 9 ]  . Ana l ys i s  by l i g h t  micros copy and E M  s how s B 
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ce l l s  d i f f e r e n t i a t i ng i n t o  a n t ibody forming c e l l s ,  o r  p l a sma 
c e l l s  [ 1 2 0 ,  1 2 4 , 1 2 5 ] . Three t o  f i ve days a f t e r  a n t i g e n i c  
cha l l enge , t h e s e  c e l l s  c a n  b e  s e e n  mi g r a t i n g  f rom t h e  g e rmi n a l  
c e n t e r  t o  medu l l a r y  cords whe re p l a sma c e l l  ma t u r a t i o n  occurs . 
I c c o s ome s a re a l s o  f o rmed and r e l e a s e d  du r i ng t h i s  t ime 
pe r i od . I t  i s  bel i e ved that  the  r e l e a s e  o f  iccosome s and t he 
s i gna l s  w i t h i n  the  g e rm i n a l  c e n t e r  mic roenvi ronme n t  a r e  
r e l a t e d  t o  t h e  i ndu c t i on o f  p l a sma c e l l  fo rma t i on [ 9 9 ] . 
T h e  s e cond p h a s e  o f  t he g e rminal  c e n t e r  re a c t i on o c c u r s  
w i t h i n  6 - 1 4  d a y s  a f t e r  a n t i g e n i c  cha l l enge . At t h i s  t ime , 
a n t i g e n  i s  r e t a i ned on t h e  FOC f o r  long t e rm r e t en t i on and 
i c c o s ome f o rma t i o n  and r e l e a s e  is  not  ob s e rved . Ge rmi n a l  
c e n t e r  B ce l l s  du r i ng t h i s  pe r i od o f  t ime be come memo r y  B 
c e l l s  a nd p l a sma c e l l forma t i on c e a s e s [ 9 0 , 9 3 ] . 
Memo r y  B ce l l s  a r e  e s s e n t i a l  i n  t h e  ma i n t e nance  o f  t h e  
humo r a l  r e spon s e . As pre v i o u s l y  s t a t e d ,  FOC c a n  r e t a i n  
u np r o c e s s e d  a n t i gen i n  t h e  f o rm o f  immune comp l e x e s  f o r  
s e v e r a l  mon t h s  t o  s e v e r a l  yea r s . T h i s  r e t a i n e d  a n t i g e n  i s  
b e l i eved to  p l a y  a c r i t i ca l  r o l e  i n  t h e  ma i n t e na n c e  o f  
a n t ibody r e spons e s . One e x i s t i ng model s t a t e s  t h a t  t h e  
conce n t r a t i on o f  FOC r e t a i ne d  a n t i gen , f r e e  a n t ibody , a n d  
a n t i ge n - a n t ibody comp l e x e s  d i c t a t e s  t h e  eve n t s  t h a t  ma i n t a i n  
t h e s e  a n t i body l e v e l s  [ 1 2 6 ,  1 2 7 ] . Expo s e d  a n t i g e n  on  t h e  
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s u r f a ce o f  t h e  F Oe w i l l  r e s u l t  i n  memo ry B c e l l  s t imu l a t i on 
a n d  a n t i body product ion . When s u f f i c i en t  amoun t s  h a ve been 
produced , the  a n t ibody will  again  bind and cove r a ny epi t opes  
expo s e d  on t h e  FOe r e t a i ned a n t i gen . The cyc l e  repe a t s  t o  
ma i n t a i n  a n d  regu l a t e  s e rum a n t i body level s .  The requ i r eme n t s  
f o r  Foe r e t a i ne d  a n t i gen t o  ma i n t a i n  a n t ibody r e sp on s e s  w a s  
f u r t h e r  s uppor t e d  b y  G r ay & S ka r va l l  i n  lymphocyt e t ra n s f e r  
s t u d i e s  [ 1 2 8 ]  . Lymphocyt e s  f r om the  t h o r a c i c  d u c t s  o f  
immu n i z e d  r a t s were  t r a n s f e r red t o  n a i v e , a n t i gen f r e e  r a t s . 
The n a i ve r a t s  were then cha l l enged a t  various  t ime p o i n t s  t o  
determine i f  B c e l l  memo ry w a s  present . T h e  re spon s e  d e c l i ned 
over  t h e  t ime course and by day t w e l ve w a s  v i r t ua l ly non­
e x i s t en t . Al t hough the  rats had the memo ry B c e l l  popu l a t i on , 
t hey l a c ked t h e  s e cond s i gn a l  o f  a n t i gen and w e r e  unab l e  t o  
ma i n t a i n  t h e  h umo r a l  immune r e s pon s e . T h e r e f o r e , t h e  
ma i n t e n a n c e  and s u rviva l o f  memory B ce l l s  i s  b e l i e ved t o  
depend on  t h e  FOe and i t s  r e t a i ne d  a n t i g e n . 
A l t hough t h e  l i t e r a t u r e  on T ce l l s  w i t h i n  t he g e rmi n a l  
c e n t e r  i s  n o t  a s  extens ive a s  t h a t  s e e n  w i t h  Foe a n d  B c e l l s ,  
T c e l l s  a re be l i eved t o  p l ay a n  e s s e n t i a l  r o l e  i n  g e rm i n a l  
c e n t e r  f orma t ion a s  evidenced b y  t h e  obse rva t i o n  t h a t  w i t hout 
t h e m ,  ge rmi n a l  c e n t e r s  do not  f o rm and t h e  a s s o c i a t e d  
immunol og i c a l  event s o f  t he ge rmi n a l  c e n t e r  d o  n o t  occur [ 1 2 9 ]  . 
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Al t hough t h e i r  exact role  i s  not known , i t  i s  b e l i eved t h a t  T 
c e l l s  i n t e r a c t  phys i c a l l y  with  B ce l l s  and p rovide help  for  T 
dependent B c e l l r e spons e s  by secreting  var ious cytokine s . I n  
support  o f  t h i s ,  recent  evidence demon s t r a t e s  t h a t  g e rmi n a l  
c e n t e r  T c e l l s  a re a n t i gen spec i f i c [ 1 3 0 ) . Norma l l y ,  a n t i ge n  
s t i mu l a t e s  a s u b s e t  o f  T ce l l s  p r e s e n t i ng t h e  r e qu i s i t e 
a n t i ge n  recept o r . Upon a n t i g e n i c  cha l l enge that  T c e l l  subset  
become s a c t i va t e d  and p r o l i f e r a t e s . N a hm e t . al s howed t h a t  
t h e s e  t wo eve n t s  occur i n  germi n a l  centers . Germi n a l  cen t e r s  
t h a t  w e r e  i nduced w i t h  a spe c i f i c  a n t i gen r e c ru i t e d  a s u b s e t  
o f  T c e l l s  t h a t  were spe c i f i c  to  that a n t i g en [ 1 3 0 )  . 
Fu r t he rmo r e , t h e s e  ce l l s  prol i f e r a t e d  i n  response  t o  t h e  
a n t i gen . The percentage o f  spec i f i c  T c e l l s  wi t h  the  expected 
TCR was  g r e a t e r  i n  the germi n a l  center than  that found i n  the 
T cell  a s s o c i a t e d  p a r a c o r t i c a l  r e g i on o f  t h e  l ymph node . 
Among i t s  funct i ons , FOC have recent l y  been s h own t o  be 
potent cos t imu l a t o r y  ce l l s  t o  both B and T l ympho c y t e s  
[ 9 9 , 1 3 1 ) . Cos t imu l a t i on p romo t e s  c e l l u l a r  p r o l i f e r a t i o n  
w i t h i n  t h i s  microenvironment . When prov i ded w i t h  a p r imary  
s i g n a l  s u c h  a s  L P S  o r  pokewee d ,  mu r i ne FOC p ro v i de 
c o s t imu l a  t i on r e s u l  t i ng i n  enhanceme n t  1 9 - 6 0 %  over  m i t o g e n  
induced B c e l l  prol i fe ra t ion [ 9 9 , 1 3 2 )  Add i t i on o f  o t h e r  c e l l 
t ypes  i n c l uding  macrophages and nude mou s e  spleen ce l l s  had no 
e f f e c t  on  p r o l i f e r a t i on . 
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Howeve r ,  FOC f rom d r a i n i n g  l ymph 
node s s h owed even g r e a t e r  enhancement of B c e l l  prol i fe r a t i on . 
We r e a s on e d  t h a t  a n t i gen recently t r apped on FOC i n  d ra i n i ng 
lymph n ode s p r ovided addi t i on a l  a c t i va t i on s i g n a l s .  T h e s e  
c e l l s ,  w h i c h  had r e c e n t l y  b e e n  l oaded w i t h  a n t i ge n  i n  vi vo, 
w e r e  t h e  mo s t  potent  c o s t imul a t o r s . I n  1 9 8 8 ,  H e i nen e t . a l 
r e p o r t e d  a s imi l a r  c o s t imu l a t o ry f u n c t i o n  i n  human FOC 
popu l a t i o n s [ 1 3 3 )  
To d e t e rmine i f  c e l l  t o  c e l l  c o n t a c t  w a s  r e qu i r e d  t o  
a c h i eve FOC a c c e s s o ry c e l l  funct i o n , FOC w e r e  r e p l a ced w i t h  
s u p e r n a t a n t s  f rom FOC c u l t u r e s . Superna t a n t s  a l one d i d  not  
enhance  L P S  i nduced B cell  prol i f e ra t i on s u gg e s t i ng that  t h e  
c e l l  t o  c e l l con t a c t  between B c e l l s  a n d  FOC i s  requi red f o r  
c o s t imu l a t i o n  o f  L P S  s t imu l a t ed B ce l l s [ 9 9 ) . 
I n  a dd i t i on t o  the  c o s t imu l a t o ry s i gna l i n g  o f  FOC , t h e  
a n t i gen p rovided b y  FOC b o t h  on  i t s  s u r f a ce and t h rough 
i c c o s ome s c on t r i butes  t o  a microenvir onme n t  condu c i ve t o  
gene r a t i ng and ma i n t a i n ing hume r a l  respon s e s . T h e  i n t e r a c t i on 
o f  FOC w i t h  B and T c e l l s  and the i n t e r a c t i o n  o f  B and T ce l l s  
w i t h  e a c h  o t h e r  a l s o  con t r i but e s  t o  t h i s  mi croenvi ronme n t . 
Ouring  c l i n i c a l  l a tency,  H I V  i s  conf ined to  the  g e rminal  
cen t e r s  o f  s e condary lymphoid t i s sue . Fu rthermore , H I V  immune 
comp l e x e s  a r e  t rapped on the  s u r f a c e  of FOC [ 6 6 ) . S i nc e  FOC 
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a r e  known t o  t r ap and r e t a i n  a n t i gen for  ma ny mon t h s  a nd 
p o s s i b l y  s e v e r a l  ye a r s , and t h i s  i s  the s i t e  o f  a c t i v e  
i n f e c t i on du r i ng c l i n i c a l  l a t e ncy,  we be l i eve t h a t  t h e  
mi c r oe n v i r onme n t  o f  the  ge rmi n a l  c e n t e r  and the  f e a t u r e s  o f  
FOC c on t r i b u t e  t o  t h e  ma i n tenance  o f  a c t i ve i n fe c t i o n  a nd t o  
t he ove r a l l pat hogene s i s  o f  AI DS . A s  t rapped a n t i g e n ,  H I V  i s  
i n  a n  a r e a  whe re s u s cept i b l e  C 0 4 + T ce l l s  cont i n u a l ly 
c i rc u l a t e . T h e s e  T c e l l s  should  be h i gh ly a c t i va t ed . T h i s  
a c t i va t i on c a n  occur  a s  a r e s u l t  o f  s e ve r a l  eve n t s  i nc l ud i n g  
F O C  c o s t imu l a t i on and p r e s e n t a t i on o f  a n t i gen i n  t h e  c o n t e x t  
o f  M H C  c l a s s  I I  b y  B ce l l s  t hrough the  a l t e r n a t e  a n t i g e n  
p a t hway . Ac t i va t ed T ce l l s  a r e  requ i red f o r  a c t i ve H I V  
repl i c a t i on and i nt e g r a t i on [ 1 3 4 ] . Once a c t i va t e d  a v a r i ety o f  
e v e n t s  c a n  f a c i l i t a t e  t h e  b i n d i n g  o f  gp 1 2 0  to  C 0 4  t h u s  
a l l o w i n g  i n f e c t i on . The FOC r e t i c u l um i s  a den s e  n e t w o r k  
t h rough w h i ch ce l l s  c i r c u l a t e  thus  opt imi z i ng the  opp o r t u n i t y  
f o r  c e l l  t o  c e l l  c o n t a c t . I n  addi t i o n ,  adhe s i on mo l e c u l e s  
s u c h  a s  I CAM- l  a nd VCAM- l o n  FOC c a n  i n t e ra c t  w i t h  L FA - l  and 
VLA- 4 on  T and B ce l l s . These  adhe s i on mol e c u l e s  p robably a i d  
i n  FOC- l ymphocyt e i n t e ra c t i on s . We be l i e ve t h a t  t h i s  p l ays 
a c r i t i c a l  r o l e  in ma i n t a i n i ng i n fe c t i on w i t h i n  the g e rmi n a l  
c e n t e r ,  e s p e c i a l ly i n  l i gh t  o f  t h e  l ow concen t r a t i on o f  C 0 4 + 
T ce l l s  p r e s en t  i n  t h i s  m i c roenvi ronme n t . W e  r e a s on t h a t  
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adhe s i on mol e c u l e s  would s t abi l i z e the FOC-T i nt e r a c t i o n  i n  a 
ma nner  t h a t  wou l d  a l low the gp 1 2 0  o f  the t rapped vi rus on FOC 
to come in c l o s e  proximi t y  to CO 4 mo l e c u l e s  on the T c e l l . 
I n  add i t i o n  t o  adhe s i on mo l e cu l e s ,  t he i n t e r a c t i on b e t w e e n  
C 0 4 0 on  F O C  a nd C 0 4 0 l i gand on T cel l s  ma y a l s o  p l a y a r o l e  i n  
fa c i l i t a t i n g  i n f e c t i on through s i gna l i ng , a c t i va t i o n ,  o r  
s e c u r i n g  the  c e l l s . F i na l l y  w i t h i n  the  g e rmi n a l  cent e r ,  FOC 
c o s t i mu l a t i on exi s t s  a s  well  a s  cytokines  produced by T ce l l s  
i n  r e s p o n s e  t o  B c e l l  i n t e ra c t ions  t h u s  caus i ng i n c r e a s e d  
p r o l i fe r a t i on and a c t i va t i on . Ta ken togeth e r ,  the  mi c r o ­
envi r onme n t  o f  the  g e rminal  c e n t e r  r ep r e s e n t s  a s i t e w h e r e  
pe rmi s s i  ve h o s t  c e l l s ,  FOC r e t a i ned i n f e c t i ou s  v i r u s , a n d  
p o t e n t  c o s t imu l a t ory s i g n a l i n g  coexi s t s . I t  i s  our hypothe s i s  
t h a t  t h i s  m i c roenvi ronmen t  and FOC p l a y a c r i t i ca l  r o l e  i n  t h e  
p a t hogene s i s  o f  H I V . The a im o f  my wo r k  was  t o  i n ve s t i g a t e  
t h e  r o l e  o f  FOC i n  H I V  pa thogene s i s  by de t e rmi n i ng i f  FOC 
t r apped H I V  was  i n fe c t ious . My res u l t s  i ndicated that it was 
h i g h l y  i n f e c t i ou s  a nd that FOC could n e g a t e  the  e f fe c t s  o f  
h i gh l e ve l s  o f  n e u t r a l i z i ng a n t ibodie s .  
METHODS 
Animals 
Fema l e ,  5 - 8  week  o l d  BAL B / c  mice were p u r c h a s e d  f r om 
Ja c k s o n  Labo r a t o r i e s  ( Ba r  Harbo r ,  ME ) . The mice w e r e  h o u s e d  
and ma i n t a ined i n  the  unive r s i ty a nima l faci l i t i e s  i n  s t andard 
s hoebox c a g e s  unde r l aminar  f l ow a i r . The mi ce were g i ven f ood 
and w a t e r  ad l ib i t um .  
Human tis s ue and b lood 
H uman t o n s i l a r  t i s s u e  w a s  obt a i ned f r om H I V  n e g a t i ve 
p a t i e n t s unde rg o i n g  s u r g e ry f o r  d i a g no s t i c  a n d / o r  p a t h o l o g i c  
r e a s on s . T h e  ma t e r i a l  w a s  prov i ded b y  the  M C V  / V C U  Ma s s ey 
Cancer  C e n t e r  T i s sue Col l e c t i on Core Fa c i l i ty or Dep a r tment o f  
P a t h o l o gy . B l ood s amp l e s  f r om H I V  i n f e c t e d  i n d i v i du a l s  were  
s upp l i e d  by D r s . Thoma s Ke r k e r i ng & Vivian B r u z z e s e  o f  t h e  
R i chmond A I DS Con s o r t i um and H I V /AI DS C l i n i c ,  r e s pe c t i ve l y . 
B l ood s amp l e s  from H I V  non - i n fected i ndividu a l s  were obt a i ned 
f r om h e a l t hy volunteers by G . Burton . Al l patient samp l e s  were  
l abe l ed t o  ma i n t a i n  con f i den t i a l i ty .  
4 0  
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HIV Preparations 
H I V - 1  l ab p a s saged s t r a i n s , 1 1 1 8 ,  MN and S F2 w e r e  
s e l e c t e d  f o r  i n i t i a l  t e s t i n g  d u e  to  t h e  r e l a t i v e  e a s e  o f  
growing  a n d  ma i n t a i n i n g  i n f e c t i ou s  v i r u s  a nd t o  t h e  
a va i l ab i l i ty o f  a n t ibod i e s  and mo l e c u l a r  r e a g en t s  f o r  t h e s e  
s t ra i n s . The s t r a i n s  1 1 1 8  and MN were c u l t u red i n  t h e  H - 9  T 
c e l l  l i ne . S F2 was  g rown i n  the Hut -78 c e l l  l i ne . I n  add i t i on ,  
t h e  p r i ma r y  H I V- 1 i s o l a t e , 3 0 1 7 1 4 ,  was  u s e d  t o  con f i rm ma j o r 
f i n d i ng s . I t  was  grown i n  PHA / I L -2  s t imu l a ted periph e r a l  b l ood 
T c e l l b l a s t s  obt a i n ed f r om H I V  non - i n f e c t e d  i nd i v i du a l s  ( s e e  
i so l a t i on o f  h uma n T ce l l s ) . C u l t u re supern a t a n t s  con t a i n i n g  
t he l a b  o r  p r ima ry i s o l a t e  o f  v i r u s  w e r e  h a r ve s t e d  f rom 
i n f e c t e d  ce l l  c u l t u r e s  a t  pea k p2 4 a c t i v i ty . They w e r e  
pool e d ,  f i l t e r e d  t h rough a 0 . 2 2 mm membrane , a l i quot e d ,  a n d  
f ro z en i n  l i q u i d  n i t rogen t o  p r ov i de a u n i f o rm s t o c k  o f  
i n f e c t i o u s  v i r u s . I n fe c t i o u s  t i t e r s  o f  v i r u s  ( T C I D50 ) w e r e  
p e r f o rmed on t hawed s amp l e s  and typ i c a l ly yie l ded t i t e r s  o f  
1 0 4 - 1 0 5 TC I D50/ml . The ACH - 2  T c e l l  l i ne was  s e l e c t e d  a s  a 
pos i t i ve c o n t r o l  f o r  a l l  exper imen t s  b e c a u s e  i t  c on t a i n s  a 
s i n g l e  c opy o f  H I V  provi r a l  DNA i n  i t s  genome . A l l  r e a g e n t s  
w e r e  obt a i ned t h r ough the  AI DS Re s e a rch and Reference Reagent 
P r o g r a m ,  D i v i s i on o f  AI DS , N I A I D ,  N I H  ( ARRR P )  as  f o l l ows:  
s t r a i n s  1 1 1 8  a nd MN , a nd the  cell  l i ne H - 9  f rom D r . Robe r t  
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G a l l o [ 1 3 S - 1 38 ] ; s t ra i n  S F2 f rom D r . Jay Levy [ 1 3 9 ] ; and ce l l  
l i ne  ACH - 2  f r om D r . Thoma s Fo l ke s [ 1 4 0 , 1 4 1 ] . 
Antibodies 
The H I V  spe c i f i c  a n t ibod i e s  s e l e c t e d  for  t h e s e  s t ud i e s  
i n c l uded: H - 9 0 2 , FI O S ,  Che s s i e  8 ,  a n d  b 1 2 . T h e  charact e r i s t i c s  
o f  e a c h  a n t i body a r e  a s  f o l l ows: 
S pe c i e s  I s otype Ep i t ope S t r a i n  N e u t r a -
recog n i zed Re a c t i v i ty l i z i n g  
H - 9 0 2  mu r i ne I gG I  gp 1 2 0  I l I B ye s 
F l O S  human I g G I  gp 1 2 0  I I I B , MN , S F2 ye s 
Che s s i e8 mu r i ne I gG I  gp4 I I l I B  no  
b 1 2  h uman I gG I  gp 1 2 0  Cl ade B ye s 
The f o l l ow i n g  r e a g e n t s  were  obt a i ned t h rough t h e  ARRRP: 
Hyb r i doma 9 0 2  f rom Dr . Bruce Chesebro [ 1 4 2 , 1 4 3 ] , FI O S  f rom D r . 
Ma r s h a l l  Posner [ 1 4 4 , 1 4 S ] , and Che s s i e  8 f rom Dr . George Lewi s . 
b 1 2  w a s  g r a c i o u s l y  p rovided by Drs . Denn i s  R .  Burton a nd P a u l  
P a r r e n , L a Jo l l a ,  CA [ 1 4 6 ] . 
An t i -C D 4  ( Leu  3 a  + 3 b ;  Becton D i c k i n s o n ) w a s  a l s o u s e d  
a s  a c o n t r o l  a n t ibody i n  s ome exper imen t s  t o  b l o c k  i n f e c t i on 
o f  h e l p e r  T ce l l s  t h rough t h e  C D 4  recept o r . 
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C ontinuous Percoll Gradients 
Cont i nuous de n s i t y  gradi e n t s  were prepared by  
cent r i fug i n g  25  ml o f  5 0 %  Pe r c o l l  s o l u t i on ( Pe r c o l l ,  dH20 ,  
Hepes  Bu f fe r ,  1 . 5M NaC l ) i n  1 x 3 . 5  i n c h  c e l l u l o s e  n i t ra t e  
u l t ra - c e n t r i fuge tubes . Gradients  we re c e n t r i fuged a t  3 0 , 0 0 0  
x g f o r  2 0  minutes  a t  4 degrees C i n  a Bec kman 5 0 . 2  T i  rotor . 
De n s i  t y  ma r ke r  beads ( Ph a rma c i a )  were added t o  one g r a d i e n t  
p r i o r  t o  c e n t r i fug a t i on to  ide n t i f y  spe c i f i c  de n s i t i e s  o f  
i n t e r e s t . 
I s olation of Human cells ( FOC ,  T cell s ,  M� , and FOC depl eted 
pop ulations ) 
Huma n ce l l s  were  ob t a i n ed f rom t on s i l s  o f  n o n - H I V  
i n f e c t e d  i n d i v i dua l s  us ing a modi f i ca t ion o f  t h e  p r o cedure 
used t o  i s o l a t e  mu r i n e  FDC f rom l ymph node s [ 1 3 1 , 1 4 7 ) . T h e  
mod i f i ca t i on c on s i s t ed o f  i n c r e a s e d  i n cuba t i on t ime s and 
v o l ume s o f  e n z yme s to  a c c ommoda te t he l a rg e r  ma s s  o f  t i s s u e  
p r e s e n t  i n  t h e  t on s i l s . B r i e f l y ,  f r e s h  huma n tons i l s  were  
c a r e f u l l y  d i s s e c t ed into 3 mm squa r e s  a nd i n cub a t e d  f o r  two 
hou r s  at  3 7  deg C i n  me d i um con t a i n i n g  c o l l a g e n a s e  ( 1 0mg /ml ) 
a n d  DNASE 1 ( 1 %  v / v ) . Fo l l owi n g  i ncuba t i o n ,  t h e  c e l l s  w e r e  
c o l l e c t e d  a nd pl aced i n  med i um con t a i n i ng 1 0 %  h e a t  
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i n ac t i va t e d ,  f e t a l  ca l f  s e rum ( FC S ) . T h e  rema i ni n g  t i s sue w a s  
a g a i n  i ncubated i n  f r e s h  med i um cont a i n i ng e n z yme s and t h e  
ce l l s  c o l l e c t e d  a s  be fore . A f t e r  the  f i n a l  i nc uba t i on o f  
t i s s ue , med i um w i t hout e n z yme s w a s  added t o  t h e  c u l t u r e  d i s h  
a n d  t he t i s s ue pipet  t e d  u p  and down g e n t l y  i n  a 1 0  m l  p i p e t  t o  
f re e  c e l l s  t r apped i n  t h e  t i s sue . Fo l l ow i n g  r e p e a t e d  
p i pe t t in g , t he c e l l s  w e r e  poo l e d ,  washed , r e s u spended i n  f r e s h  
med i um and l a ye red o n t o  5 0 %  cont i nuous P e r c o l l  gradien t s . T h e  
g r a d i e n t s  w e r e  c e n t r i fuged a t  5 0 0  x g for  3 0  min . T h e  l ow 
dens i t y  band ( 1 . 0 5 0 - 1 . 0 6 0  g /ml ) con t a i n i n g  FOC and ma c rophages  
w a s  c o l l e c t e d  a s  was  the  h i g h  dens i t y  band ( 1 . 0 7 5 - 1 . 08 5 g /ml ) 
c on t a i n i n g  T c e l l s . Both  f r a c t i on s  were  w a s hed f r e e  o f  
P e r c o l l  a n d  r e s u s pended i n  med i a  con t a i n i ng FCS p r i o r  t o  
addi t i o n a l  ma n i pu l a t i on s . 
I n  s ome exper imen t s , FOC were f u r t h e r  e n r i ched u s i n g  
f l or e s cence a c t ivated c e l l  s o r t i n g  ( FAC S )  [ 1 3 1 , 1 4 7 )  FOC w e r e  
s t a i ne d  u s i n g  two , mu r i ne I gM ,  a n t i - human F O C  mon o cl on a l  
a n t i b od i e s: H J 2  ( p rov i ded b y  O r . M .  N a hm )  [ 1 4 8 , 1 4 9 )  a n d  ORC - 1 
( Oa ko )  . A f t e r  w a s h i ng t o  remove unbound a n t ibody , t h e  
prepa r a t i on s  w e r e  s t a i ned w i t h  b i o t i n  con j ugated don key a nt i ­
mou s e  I gM ( Ja c k s o n  Immuno Re s e a rch ) f o l l owed b y  a f i n a l  w a s h  
a n d  i ncuba t i on w i t h  s t repavi d i n  f l uorochrome ( FI T C  o r  PE ; 
T a go ) . T h e  c e l l s  were t he n  s o r t e d  b a s e d  on  a n t i - FOC 
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f l o r e s ce n c e  and f o rw a rd l i ght s c a t t e r  u s i n g  a Cou l t e r  E p i c s  
7 5 3 . 
Fo r a l l  o t h e r  s tu d i e s  FDC were f u r t h e r  e n r i ch e d  u s i n g  
pos i t i ve s e l e c t i on o n  a magne t i c  act ivated ce l l  s o r t e r  ( MACS ) 
i n s t e a d  o f  FAC S s ca n n i n g . A f t e r  i n cuba t i on w i t h  HJ2 , t h e  
prepa r a t i o n  wa s was hed t o  remove unbound a n t i body and t h e n  
i n cuba t e d  w i t h  r a t , a n t i -mouse 1 9M ma gne t i c  
m i c robe a d s ( M i c robe a d s ; M i l tenyi  B i o t e c ,  GmbH ) . C e l l  
s u spe n s i on s  were  l a yered over a c o l umn a t t ached t o  a ma g n e t . 
M i c r ob e a d s  bound t o  ce l l s  were  a t t r a c t e d  to  t h e  ma g n e t  a n d  
t h u s  rema i n e d  i n  the  c o l umn wh i l e  o t h e r  ce l l s  w i t ho u t  bound 
beads p a s s e d  t h rough . The col umn was  then removed f r om the 
ma g n e t  and w a s hed with med i um to  c o l l e c t  t he d e s i red c e l l s . 
Re s u l t i n g  prepa r a t ions con s i s t ed o f  FDC w i t h  a p u r i t y  o f  
>85 % based o n  f l ow cytome t r y . The FDC showed t yp i c a l  dendr i t i c  
morp h o l o g y ,  s t r u c t u r e  and f u n c t i o n . FDC prepa r a t i on w a s  y­
i r r a d i a t ed ( 3 0 0 0 R )  p r i o r  to  i n cuba t i on w i t h  H 1 V  immune 
comp l e x e s  t o  b l o c k  prol i f e r a t i on and thus minimi ze  the  abi l i t y  
o f  c e l l s  i n  t h i s  p repa r a t i on t o  s uppo r t  H 1 V  i n f e c t i on . 
MAC S w a s  a l s o  u s e d  to  p repa re tons i l a r  ma c r opha g e s  
( po s i t i ve l y  s e l e c t e d  u s i n g  a n t i -C D 1 4 M i c robeads ) ,  t o n s i l a r  T 
ce l l s  ( po s i t i ve l y  s e l e c t e d  u s i ng a n t i - C D 3  and a n t i - C D4 
mi c r obeads ) a nd FDC de f i c i e n t  c e l l  popu l a t i o n s  ( ne g a t i v e l y  
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s e l e c t e d  i . e .  t h o s e  ce l l s  not binding to  the  magne t i c  col umn 
when r e a c t ed w i t h  a n t i - FOC mAb s ) . 
For s ome exper iment s ,  peripheral bl ood C 0 4 + T ce l l s  were  
s ub s t i t u t e d  f o r  t on s i l a r  T ce l l s . I n  addi t i on , p e r i ph e r a l  
b l ood T c e l l s  were u s e d  to  c u l t ure t h e  pr ima ry H I V - 1  i s o l a t e , 
3 0 1 7 1 4 . B l ood was obt a i ned from norma l dono r s  and periphe r a l  
b l ood mononu c l e a r  ce l l s  ( PBMC ) were e n r i ched on  L ymphocyte  
Sepa r a t i on Medium ( LSMi Organon Techn i ka )  . B r i e f l y ,  bl ood w a s  
d i l u t e d  i n  h a l f  w i t h  med i um and l a ye red o v e r  7 m l  LSM i n  1 5ml 
con i c a l  c e n t r i fu g a t i on t ube s . The tubes were  cent r i f u g e d  a t  
4 0 0  x g f o r  2 0  m i n u t e s  a t  2 5  degrees  C .  Lymphocyt e s  w e r e  
c o l l e c t ed f o rm t he t i s s u e  c u l t u re me d i um-LSM i n t e r f a c e  and 
f u r t h e r  p u r i f i ed by s o r t i ng u s i n g  po s i  ti  ve s e l e c t i on w i t h  
a n t i - C 0 3  a nd a n t i - C 0 4  magn e t i c  mi c robeads . 
FOC trappi ng of H IV- l in vi t ro 
Human t o n s i l a r  FOC were i ncubated ove r n i g h t  ( 4 °C ) w i t h  
H I V - immun e  c omp l e x e s  formed by i ncuba t i n g  ( 2  h r ,  3 7 °C ) 1 0 0 p l  
f r e s h  f ro z e n  s e r um f r om a n  H I V  i n f e c t e d  i nd i v i d u a l  ( a s  a 
source o f  speci f i c  a n t ibody and compl ement ) w i t h  1 0 0  p l  H I VI I I _B 
c e l l  f r e e  s upe rnatant  ( 5 0 0 0  TC I 050 ) . Th i s  do s e  o f  H I V  p rovi ded 
s u f f i ci e n t  v i r u s  for  immune comp l e x  f o rma t i on and s ub s equent  
t r ap p i n g  b y  FOC . H I V- immune comp l e x e s  not  bound t o  FOC w e r e  
r emoved b y  w a s h i ng . 
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B i nd i n g  o f  v i r i on s  t o  F OC was  con f i rmed 
by e l e ct ron m i c r o s c opy . 
FOe trapping of H IV- l in vivo 
To f o rm and t rap H I V  immune comp l e x e s  onto  FOC i n  vi vo 
mi c e  w e r e  i n j e c t e d  w i t h  spe c i f i c  a n t i body and a n t i ge n . For 
o u r  s y s t em ,  we p e r f o rmed t h i s  by f i r s t  i n j e c t i n g ( s c o r  i p ) 
1 . 2  mg , mu rine  a n t i - gp 1 2 0  mAb i n t o  mi ce . Two hours l a t e r ,  the  
a n ima l s  were  exposed t o  600R v- i r r a di a t i on t o  e l im i n a t e  
radi a t ion s e n s i t i ve l ymphocytes a n d  thus  e n r i ch for  radi a t i o n  
re s i s ta n t  F OC [ l 1 6 , 1 4 7 ] . One d a y  l a t e r  mice received i n j e c t i on s  
o f  H I V1 I I B  t o  a l l ow immune complex  fo rma t i on and F O C  t rapp i ng 
i n  v i vo . 5 0 0 0 T C I  050 1 s i  t e  o f  H I V  ( f i ve s i t e s  t o t a l )  w a s  
i n j e c t e d  i n  the  f e e t  and behind  t h e  n e c k  t o  d i s t r i b u t e  t h e  
vi r u s  t o  F OC i n  several  dra i n i ng l ymph node s . T h i s dose o f  H I V  
r e s u l  t e d  i n  con s i s t en t  b i nding  o f  H I V  on F OC i n  mu l t i p l e  
d r a i n i n g  l ymph node s . Five days l a t e r ,  when immune comp l e x e s  
o r  a n t i ge n s  
s a c r i f i ce d  
a re con f i ned t o  mu r i ne FOC [ 1 2 7 ] , t h e  mice  w e r e  
b y  e t he r  a n e s t he s i a  fol l owed by c e r v i c a l  
d i s l o c a t i on and t h e  l ymph nodes e x c i sed ( i n c l u d i n g  t h e  
pop l i  t e a l ,  b r a ch i a l , a x i a l  and s ubmandibu l a r ) . FOC w e r e  
i s o l a ted a s  de s c r i bed [ 1 4 7 ]  These prepa r a t i ons  cont a i ned 2 5 -
4 5 %  FOC w i t h  t h e  rema i n i ng c e l l s  being equal numb e r s  o f  T and 
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8 l ymph o c y t e s . 
Neutralized HIV immune complexes 
H I V  immune comp l e x e s  were  formed by m i x i n g  pi cogram,  
mi c rogram, o r  mi l l i g r am dos e s  o f  n e u t r a l i z i ng mu r i ne a n t i - H I V ­
l I I I B  gp 1 2 0 ,  H - 9 0 2 , w i t h  S O O OTCI Oso H I VI J 1 B . H I V - immune comp l e x e s  
were a l s o  fo rmed u s i ng H I V - l  s t ra i n s  ( I I I 8 ,  M N  and S F- 2 ) mi xed 
w i t h  1 pg  h uman a n t i - H I V - l  g p 1 2 0 ,  Fl O S ,  and the  p r ima r y  
i s o l a t e  3 0 1 7 1 4  m i x e d  w i t h  2 0mg mono c l o n a l  a n t i body b 1 2 . 
C o n t r o l  c u l t u r e s  i n c l uded the  u s e  o f  a non-neut r a l i z i n g  
a n t i body , Che s s i e  8 ,  mi xed w i t h  S O O OTC I Oso H I VI I I B . T h i s  dose  
o f  HIV  w a s  u s e d  t o  provide a h i g h  l e ve l  o f  v i r u s - a n t i - v i r u s  
immune c omp l e x e s  s u c h  a s  could pote n t i a l l y  e x i s t  on  FOC i n  
vi vo . 
Experimental Tests 
T o  d e t e rmi ne i f  FOC t r apped H I V  was  i n f e c t i ou s , we 
c u l tured FOC b e a r i n g  HIV immune complexes  ( a s  the on l y  s ou r c e  
o f  v i r u s ) w i t h  h uman C 0 4 + T c e l l s  w h i c h  had been a c t i va t e d  
ove r n i g h t  w i t h  S t aphylococcal  E n t e rotoxin  E ( SE E ) ( To x i n  
Technol ogy , S a ra s ot a ,  FL ) . Human ton s i l a r  F OC ( 6 x l 0 4 ) b e a r i ng 
H I V  t r apped � n  vi t ro o r  c o n t r o l  FOC were cocu l t u r e d  w i t h  
l x l O S ,  S E E  a c t i v a t e d  ( 1 0 0  p g /ml ) , a u t o l ogous C 0 4 +  T c e l l s . 
M u r i n e  FOC 
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b e a r i n g  i n  vi vo t rapped H I V  immune 
complexes  were coc u l t u r ed with  1 x 1 0 5 S E E  ( 5  ng /ml ) a c t i va t ed 
T c e l l s , obt a i ned f rom p e r iphe r a l  bl ood . 
T o  d e t e rmine i f  FOC c o u l d  negate  t h e  e f fe c t  o f  
neut r a l i z i n g  a n t i body , neutra l i zed immune comp l ex e s  were f i r s t  
fo rmed a t  3 7°C f o r  1 hr  and then i ncuba t e d  w i t h  S E E  a c t i v a t e d  
t on s i l a r  T c e l l s  ( 5 x 1 0 4 ) o r  t h e  H - 9  T ce l l  l i ne . MAC S  
pu r i f i e d  human ton s i l a r  FOC ( l x 1 0 4 ) were a l s o  added t o  s ome o f  
t h e  c u l t u re s . T o  p rove t h a t  i t  w a s  FOC a n d  n o t  contami n a t i ng 
c e l l s  t h a t  were  re spon s i b l e  for  nega t i ng the  e f fe c t  o f  t h e  
a n t ibody , we a l s o  c u l t u red neut r a l i zed immune compl exes  a n d  T 
ce l l s  w i t h  MAC S  p u r i f i e d  ma c r oph a g e s  and FOC dep l e t e d  
popul a t i on s  a t  a conc e n t r a t ion o f  1 x 1 0 4 c e l l s  p e r  we l l . I n  
a dd i t i o n ,  b l o c k i n g  a n t i - C D 4  w a s  added t o  s ome c u l t u r e s  a t  a 
dose  o f  1 �g t o  con f i rm t h a t  i n fe c t i on wa s occu r r i ng v i a  
gp 1 2 0 - C 0 4  receptor  b i n d i n g . 
Al l c u l t u r e s  were  p e r f o rmed i n  t r ip l i ca t e  i n  4 8  we l l  
p l a t e s  w i t h  med i a  con t a i n i ng 1 0 %  FCS . P l a t e s  w e r e  i n cuba t e d  
f o r  4 days  a t  3 7  degrees  p r i o r  t o  a na l y s i s  o f  i n f e c t i o n . 
Detection of HIV infection by peR & S outhe rn blot analy s is 
Samp l e s  were centri fuged and the DNA i so l a t ed u s i n g  l y s i s  
bu f f e r  a nd p r o t e i n a s e  K a s  d e s c r ibed ( 1 5 0 )  DNA was  s t ored a t  
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- 2 0°C u n t i l  t e s t e d . PCR a n a l y s i s  f o r  H I V  prov i r a l  gag and 0 -
g l ob i n  s e quen c e s  was  pe r fo rmed i n  the  s ame r e a c t i on ve s s e l  
u s i n g p r ime r pa i r s  SK 3 8 / 3 9 [ 1 5 1 ]  and GH2 0 / PC 0 4 [ 1 5 2 ] 
r e s p e c t i ve l y . Cont r o l  c u l t u r e s  o f  ACH - 2  ce l l s  were i s o l a t e d ,  
a n d  d i l u t e d  a s  indicated w i t h  uni n fe c t ed H 9  c e l l s  t o  provide 
a c on s t a n t  amount o f  c e l l u l a r  DNA p r i o r  t o  i s o l a t i on f o r  PCR 
a n a l ys i s . PCR amp l i f i c a t i on was per formed for  35 cycle ( 9 4 °Cx2 
min 1 s t  c y c l e ,  9 2  °C x 1  min a l l  o t h e r  cyc l e s ; 5 5 °  Cx 1 . 5  min ; 
7 2  °Cx 2 mi n ;  a f t e r  c yc l e  3 5 ,  an  addi t i on a l  7 2° Cx  7 min 
i n c uba t i on w a s  pe r fo rmed ) . Ampl i f ied produ c t s  ( 1 0 11 1 )  w e r e  
ana l y z e d  b y  e l e c t r opho r e s i s  ( 2 %  a g a r o s e ) ,  s t a i ne d  w i t h  
E t h i d i um B romi de f o r  0 - g 1 ob i n  de t e c t i on ,  a n d  b l o t t ed o n t o  
N y t r a n . B l o t s  were  p r obed u s i ng 3 2 p  l abe l e d  S K 1 9 [ 1 5 1 ] . 
Au t o r a d i o g r aphy was p e r f o rme d f o r  3 days a t  
Aut o r a d i o g raphs  and P o l a r o i d  p r i n t s  o f  e t h i d i um s t a i ne d  ge l s  
we re s canned a t  4 0 0 dp i ,  a l igned us ing M i c r o s o f t  Powe r Poi n t , 
t r a n s f e r r e d  t o  f i lm and p r i n t e d  on Koda k F5 r e s i n  c o a t e d  
pape r . 
E lectron Micros copy 
C u l t u r e s  con t a i n i ng T c e l l s ,  FDC , and H I V  immune 
comp l e x e s  ( fo rmed with H I V- I I I B and the  neut r a l i z i ng a n t ibody­
H 9 0 2 ) were a n a l y z e d  by e l e c t ron micros copy . T h r e e  to 5 days  
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a f t e r  c u l t u r i n g , g e rm i n a l  c e n t e r  c l u s t e r s  were i s o l a t e d  and 
g e n t l y  f i xed by 2 . 5 % g l u t a r a l de h yde i n  sodium c a codyl a t e  
bu f fe r  f o r  2 hours [ 1 5 3 )  T h i s  was fol l owed b y  f i x a t ion i n  . 5 % 
Osmium T e t ra Oxide for 9 0  minute s .  They were next  p o s t  f i x e d  
w i t h  1 %  T a n n i c  Acid A R  ( an A l l epo nut  de r i va t i ve ;  T A  
Ma l l i n c k r odt , NO . 1 7 6 4 ,  S t . Lou i s ,  MO ) i n  0 . 0 5 %  s o d i um 
c a c odyl a t e  bu f f e r  a t  amb i e n t  tempe r a t u r e  for  2 0  minut e s . 
Fix a t i on was  f o l l owed by rou t i n e  embedding i n  8 1 2  epoxy r e s i n . 
Samp l e s  were  s e c t i oned on a n  O l t ra - M i c r o t one . S e c t i o n s  were  
t h e n  s t a i ne d  i n  u r a n y l  a c e t a t e and l e a d  c i t r a t e  and e x amined 
on a Z e i s s  10  CA E l e c t ron M i c r o s cope [ 1 5 3 ) . 
HIV Quantitation 
I n  a n  a t t emp t t o  qua n t i t a t e  i n t e g r a t e d  provi r a l  DNA , we 
de s i gned a c omp e t i t ive PCR a s s a y  ( C l one t e c h ) . C ompe t i t i v e  
f r a gmen t s  o f  n e u t r a l  DNA ,  Ve rb , we re de s i gned i n  a manner  t h a t  
wou l d  a l l ow t hem t o  be amp l i f i e d by o u r  p r ime r s  S K 3 8 / 3 9 ,  b u t  
wou l d  g e n e r a t e  a product t h a t  wou l d  b e  2 0 0  b a s e  pa i r s  l o n g e r  
t h a n  t h e  gag amp l i f i c a t i on produc t . B r i e f l y ,  prime r s  w e r e  
g e n e r a t e d  w h i c h  wou l d  amp l i fy t h e  neu t r a l  p i e ce o f  DNA , b u t  
w e r e  a l s o f l a n ke d  a t  t h e i r  5 '  end w i t h  S K 3 8 a nd S K 3 9  
s e q u e n ce s . A f t e r  amp l i f i ca t i on w i t h  t h e s e  p r ime r s ,  t h e  
product g e n e r a t e d  c on t a i ned V e r b  DNA f l a n ked by gag DNA S K 3 8  
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a nd S K 3 9 s equence s . T h i s  product was  amp l i f i e d a g a i n  w i t h  
S K3 8 / S K 3 9  p r ime r s  i n  a s e conda ry peR . The s e c onda r y  p r oduct 
v e r i f i ed that amp l i f i c a t i on could occur with SK 3 8 / S K 3 9 . T h i s 
product t h e n  s e r ves a s  a compe t i t i ve f r a gme n t  i n  p e R  
r ea c t i on s . 
T o  quan t i t a t e , experimen t a l  samp l e s  a r e  " s p i ked" w i t h  
varyi n g ,  y e t  known conce n t r a t ions o f  t h e  comp e t i t ive f r a gmen t . 
p e R  amp l i f i ca t ion i s  p e r f o rmed w i t h  SK3 8 / S K 3 9 p r ime r s  w h i c h  
w i l l  amp l i f y both  H I V  provi r a l  DNA and the  c ompe t i t i v e  
f r a gmen t . P rodu c t s  a r e  run on  a g a r o s e  g e l s  a nd s t a i n e d  w i t h  
e t h i di um b r omide . T h e  i n t e n s i t y  o f  t h e  mimi c f r a gmen t  i s  
compared t o  t h a t  o f  t h e  unknown s amp l e . Where t h e  i n t e n s i t i e s  
ma t c h ,  t h e  two DNA s amp l e s  equa l l y  competed f o r  t h e  p r i me r s , 
t he r e fore the  concent r a t ion o f  the  compe t i t i ve f r a gmen t  equ a l s  
t h e  conce n t ra t i on o f  t h e  s amp l e .  T h e  s e n s i t i v i t y  o f  t h e  
c ompe t i t i ve p e R  g e n e r a t e d  h e r e  i s  a t  t h e  a t t omo l a r  r a n g e . 
RESULTS 
I n  t h i s  repo r t , we d e s c r i b e  an i n  vi t ro mod e l  of t h e  
g e rmi n a l  c e n t e r ,  de s i gned t o  mimi c eve n t s  d u r i n g  c l i n i c a l  
l a t e n c y ,  t o  d e t e rmine whe t h e r  o r  not FOC r e t a i ned H I V  c ou l d  
c a u s e  i n f e c t i on . We obt a i ned FOC from t h e  ton s i l s  o f  H I V  non­
i n f e c t e d  i n d i v i du a l s  and i n cuba t e d  these w i t h  H I V- immune 
c omp l e x e s  i n  vi t ro . V i r a l  immune comp l e x e s  not  bound t o  F OC 
were removed by washing  and FOC were c u l t u red w i t h  a c t i va t e d ,  
a u t o l ogous  C 04 + T ce l l s . I n fe c t i on was  mon i t o red b y  P C R  
a n a l ys i s  o f  DNA f rom the  c u l t u re s . I n fe c t i on was  demon s t r a t e d  
by t h e  p r e s en c e  o f  provi r a l  H I V - 1  DNA i s o l a t e d  f r om c u l t u r e s  
o f  T ce l l s  a n d  FOC bea r i ng H I V- immune c omp l e x e s  b u t  n o t  i n  
c u l t u r e s  c on t a i n i ng c o n t r o l  FOC ( Fi g  2 )  Syncyt i um f o rma t i o n  
w a s  a l s o  ob s e rved i n  cultures  o f  T c e l l s  and FOC bea r i n g  H I V­
immune c ompl exes . H I V  b i nd i ng t o  FOC was  con f i rmed by e l e c t ron 
mi c r o s copy ( no t  s h own ) . P o r t i on s  o f  FOC dend r i t i c  p r o ce s s e s  
bore 5 - 1 0  v i rus pa r t i c l e s  e x t r a ce l 1 u l a r l y  which i s  con s i s t ent  
w i t h  ob s e rv a t i o n s  i n  v i vo [ 6 4 , 1 5 4 , 1 5 5 ) . The di s t r i b u t i on of  
HIV  v i r i o n s  on FOC proce s s e s  s ugge s t ed t h a t  a T c e l l  c ou l d  
i n t e ra c t  w i t h  seve r a l  v i r u s  p a r t i c l e s  on  a s i n g l e  por t i on o f  
a n  FOC p roce s s . 
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F i g u r e  2 :  I n f e c t i on o f  T c e l l s  by FOC t rapped H I V- l . C 0 4 +  T 
c e l l s  and a u t o l ogous FOC bea r i ng H I V  immune complexes  t rapped 
in v i t ro w e r e  c u l t u r e d  and in f e c t i o n  mon i t ored u s i n g  PCR . 
P rovi r a l  H I V  - 1  gag ( 1 1 5bp ) ONA was detected whe re FOC bea r i ng 
H I V - 1  were  u s e d  a s  t he on l y  source o f  v i r u s  f o r  i n f e c t i on o f  
t h e  T c e l l s . L y s a t e s  o f  decrea s i ng numb e r s  o f  ACH - 2  c e l l s ,  a 
c h r o n i c a l l y  i n fe c t e d  T c e l l  c l one cont a i n i n g  one copy o f  
p r ov i r a l  ONA p e r  ce l l ,  were r u n  i n  para l l e l  f o r  compa r i s on . 
T h e  i n t e n s i t y  o f  the  s i gnal  f rom T ce l l s  i n f e c t e d  b y  FOC 
bea r i ng H I V- i mmune c omp l e x e s  appea red between t he i n t e n s i t y  
ob t a i ne d  f r om 1 0 3  t o  1 04 ACH - 2  c e l l s . A s  a c o n t r o l , f) - g l o b i n  
ONA w a s  amp l i f i ed s imu l t aneou s l y  ( bot t om ) . T + S E E  = T c e l l s  
a c t i va t e d  w i t h  S t aphylococca l E n t e r o t ox i n - E ; FOC - H I V  ( I C )  
FOC incubated w i t h  H I V- 1 I I I B  immune comp l e xe s ;  FOC = c on t ro l  
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H I V- immune c omp l e x  t rapping  o n  FOC i n  vi t ro ma y d i f fe r  
f rom t r app i n g  i n  vi vo .  We t h e r e fore exami ned t h e  i n fe c t i v i t y  
o f  H I V  t rapped o n  FOC i n  vi vo u s ing a mu r i n e  mode l . P r e v i o u s  
wo r k  h a s  s h own t h a t  F O C  can  provide a c c e s s o r y  f un c t i on t o  
j 
l ymphocyt e s  a c r o s s  spec i e s  ( Burton unpub l i s hed ) a nd we 
rea s oned t h a t  H I V- l  gp 1 6 0 on FOC - t rapped v i rus could i n t e r a c t  
w i t h  human C 0 4  on T c e l l s  regardl e s s  o f  FOC spec i e s . An t i ge n s ,  
i n c l ud i n g  v i r u s , c a n  be l oca l i z ed on mu r i n e  FOC i n  vi vo b y  
pa s s i ve immu n i z a t i on f o l lowed by a n t i ge n  cha l l enge [ 1 2 0 , 1 5 6 ) . 
FOC t rapp i n g  o f  H I V  was  a c comp l i s hed by p a s s i v e l y  immu n i z i n g  
m i c e  w i t h  H I V - 1 I I 1 B spec i f i c  a n t i - gp 1 2 0  a n d  one da y l a t e r ,  
i n j e c t i ng 5 0 0 0  TC I Oso H I V I I I B in  several  s i t e s  t o  a l l ow t r apping 
o f  H I V  immun e  comp l e x e s  on FOC in  mu l t i p l e  l ymph node s . Fi ve 
days l a t e r  d r'a i n i n g  l ymph node s were ob t a i ned and the FOC 
i s o l a t ed [ 1 4 7 ) . The mu rine FOC b e a r i ng HIV t r apped i n  vi vo were 
c o c u l t u red with  a c t i va t e d  human T c e l l s  o b t a i n e d  f r om t h e  
b l ood o f  a n o rma l dono r  ( Fi g  3 ) . I n f e c t i o n  o f  human T c e l l s  
w a s  de t e c t e d  when H I V  immune comp l e x e s  o n  mu r i n e  FOC w e r e  
u s e d  a s  t he o n l y  source  o f  v i r u s . T r a n s f e r  o f  i n f e c t i on b y  
mur i ne F OC a l s o  i n d i c a t e d  t h a t  H I V  i n f e c t i on o f  F O C  w a s  n o t  
needed b e c a u s e  the  mou s e  i s  a non-permi s s i ve hos t . T h i s  model  
a l s o  e x c l uded the  po s s i b i l i t y  that  human C 0 4 + ce l l s  i n  t he FOC 
p repa r a t i o n  w e r e  needed for t ra n s f e r  of i n f e c t i on . 
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F i g u r e  3 :  T ce l l  i n f e c t i on by H I V - l  t r apped o n  mu r i ne F OC i n  
vi vo . Xenoge n e i c  ( mu r i n e ) FOC b e a r i n g  H I V- immune c omp l e x e s  
t rapped i n  vi vo were c u l tured w i t h  human C 0 4 +  T ce l l s  a n d  
i n f e c t i on mon i t ored u s i ng PCR . I n f e c t i on was  c l e a r l y  evident  
w h e r e  human T ce l l s  were c u l t u r e d  with  FOC  b e a r i ng i n  vi vo 
t r apped H I V  w e r e  used  a s  t h e  on l y  s ource  o f  v i r u s  f o r  
i n f e c t i on [ T + S E E + F OC - H I V  ( t rapped i n  vi vo)] . I n f e c t i on w a s  
a l s o  d e t e c t e d  w h e r e  cont rol , mur i n e  F O C  ( no H I V  t r apped ) w e r e  
i ncuba t e d  w i t h  human T c e l l s  i n  the  p r e s ence o f  exogenous H I V  
( 5 0 0 0  TC I Oso ) a nd t h i s  s i gn a l  appeared s l i g h t l y  mo r e  i n t e n s e  
t h a n  t h a t  obta ined f rom the  F O C  w i t h  i n  vi vo t rapped H I V . I n  
c o n t r a s t , n o  p r ov i r a l  ONA s i g n a l  wa s obt a i n e d  w h e n  t h e  s ame 
FOC b e a r i ng v i r u s  were  c u l t u r e d  w i t h  r e s t i n g  human T c e l l s  
[ T + FOC- H I V ( t r apped i n  vi vo)] indi c a t i ng t he need f o r  T c e l l  
a c t i  v a t i on t o  s uppo r t  i n f e c t i on b y  t h e  t r apped v i r u s . N o  
prov i r a l  ONA s i gn a l  w a s  ob se rved i n  control c u l t u r e s  o f  e i t h e r  
the  human T c e l l s  a l one or the  mu r i ne F O C  bea r i n g  H I V  t r apped 
i n  vi va . ACH - 2  ( 5 x l 0 4 ) were i n c luded a s  a p o s i  ti ve c o n t r o l . 
T h e  abi l i t y  o f  H I V  on xenogene i c  FOC t o  i n f e c t  human T c e l l s  
w a s  n o t  unexpe c t e d  s i nce t h e r e  i s  no a pri o r i  r e a son t h a t  
gp 1 2 0  on FOC t r apped v i rus could n o t  i n t e r a c t  w i t h  C 0 4  p r e s e n t  
on t he human T c e l l s . Fur t h e rmore , mu r i ne dendr i t i c  ce l l s  ( OC ,  
n o t  t o  b e  c o n f u s e d  w i t h  FOC ) have a l s o  s u cc e s s f u l l y  i n f e c t ed 
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The mono c l ona l a n t i body ( H 9 0 2 ) used t o  t r a p  H I V  o n  t h e  
mu r i n e  F O C  h a s  b e e n  u s ed to  neut ral i ze H I V - 1 I I I B [ 1 4 2 ] . The H I V  
c omp l e x e s  t r apped on F OC i n  vi vo w e r e  i n f e c t i o u s ; t h e r e fore , 
we r e a s oned t h a t  FOC may be able  to  reve r s e  the  e f f e c t  o f  
n e ut r a l i z i ng a n t i body . T o  t e s t  t h i s ,  neu t r a l i z e d  H I V - 1 J I l B 
immune c omp l e x e s  were  f o rmed i n  vi t r o  u s i n g i n c r e a s i ng d o s e s  
o f  n e u t r a l i z i ng a n t ibody and c u l t u red w i t h  t h e  H - 9  T c e l l  
l i ne ( da ta n o t  s hown ) o r  a c t i vated T c e l l s  i n  t h e  p r e s e n c e  or 
absence o f  FOC ( Fi g  4 ) . One nanog ram o f  a n t i body con s i s te n t l y  
n e u t r a l i z e d  5 0 0 0  T C I 050 H I V - 1 I I I B ( Fi g  4 a ) . I n f e c t i on o c c u r r e d  
w h e n  FOC were p r e s e n t  a t  dos e s  o f  n e u t r a l i z i n g  a n t ibody 
-
ranging f rom 1 thousand t o  1 mi l l i on fold above the  1 nanogram 
needed t o  prevent i n f e c t i o n  i n  the absence o f  FOC ( Fi g  4 b & c ) . 
Ton s i l a r  mac rophages  and ton s i l a r  c e l l s  spe c i f i ca l l y  dep l e t e d  
o f  F O C  f a i led t o  promot e  i n fe c t ion by ne u t r a l i zed H I V - 1  immune 
comp l ex e s  ( Fi g  4 c ) . An t i - C 0 4  i n  c u l t u r e s  o f  HIV  immune 
c omp l exe s ,  T ce l l s  a nd FOC b l oc ked i n fe c t i on con f i rming t h e  
impor t ance o f  t h e  s u r face ma r k e r  C 0 4 . A s  expe c t e d ,  i ncub a t i on 
o f  t h e  v i r u s  w i t h  Ch e s s i e  8 ,  a nonneut r a l i z i n g  a n t ibody , 
r e s u l t ed i n  i n f e c t i on o f  T ce l l s  i n  t he pre sence  and a b s e n c e  
o f  FOC ( Da t a  not  s h own ) . I nc r ea s i ng amoun t s  o f  n e u t ra l i z i ng 
a n t i body reduced the  amount o f  provi r a l  H I V - 1  gag d e t e c t e d  
i n d i c a t i n g  t h a t  even t hough a n t ibody did n o t  b l o c k  H I V  on FOC , 
6 0  
Figure 4 :  FOC med i a t e  H I V  i n fect ion o f  T c e l l s  i n  the  p r e s e n ce 
o f  n e u t r a l i z i ng a n t ibody . PCR amp l i f i ca t ion o f  H I V  p rovi r a l  
DNA ( t op p a n e l s )  a n d  c o n t r o l  � - g l ob i n  DNA ( bo t tom)  f rom 
c u l t u r e s  of SEE a c t i va t ed C 0 4 + T c e l l s  ( T +SEE ) and H I V- immune 
comp l e x e s  ( H I V- I C )  formed w i t h  va r i ou s  d o s e s  of neu t r a l i z i n g  
a n t ibody i n  t h e  absence ( a )  or p r e s ence o f  huma n FOC ( b & c ) . a )  
I n fe c t i o n  o f  SEE  a c t i va t ed C 0 4 + T ce l l s  by H I V - 1 I I I B immune 
c omp l e x e s  f o rmed with  1 pi cog ram o f  n e u t r a l i z i n g  a n t i - gp 1 2 0  
( H 9 0 2 )  w a s  evident  whe r e a s  i n fe c t i on was  b l o c ked when v i r a l  
c omp l e x e s  w e r e  f o rmed u s i ng 1 n a nog ram,  1 mic r o g r am a n d  1 
mi l i g r am o f  a n t ibody . S i gn a l  i nten s i t y  i s  compared w i t h  5 0 , 0 0 0  
AC H - 2  c e l l s . ( b  & c - l e f t  pan e l ) Add i t i o n  o f  FOC t o  c u l t u r e s  
r e v e r s e s  t h e  e f fe c t  o f  neut ra l i z i ng a n t ibody e v e n  i n  v a s t  
e x c e s s  o f  t h e  1 nanogram quant i t y  needed t o  b l o c k  i n f e c t i on 
when FOC were not  p r e s e n t . ( c - r i g h t  pane l )  T on s i l a r  
mac r ophages  ( M$ )  and t on s i l a r  c e l l s  depleted o f  FOC ( FOC dep ) 
cou l d  not  s ub s t i tute  for  FOC i n  promo t i n g  i n f e c t i on by H I V - I C  
f o rmed w i t h  1 nanogram o f  n e u t r a l i z i ng a n t i body . Add i t i on o f  
a n t i - C 0 4  b l o c ked i n f e c t i on even when FOC were p r e s e n t  i n  t h e  
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i t  d i d  appe a r  to  decrea s e  infect i on ( Fi g  4 b &_c ) . C u l t u r e s  were 
a l s o  a n a l y z e d  by e l e c t ron mi c r os copy and v i r u s  budding f r om 
t h e  p l a sma membrane was  obs e r ved ( f i g u r e  S a - c ) . 
Immune complexes  we re fo rmed w i t h  l a b  i s o l a t e s  H I V - 1 [ I 1 B ' 
H I V - 1 � ,  and H I V- 1 sn and t h e  p r ima r y  i s o l a t e  3 0 1 7 1 4  and h uman 
neut ra l i z ing monoc lonal ant ibod i e s  ( F 1 0 S  or I g G 1b 1 2 ) in order 
to de t e rmine the  general nature o f  i n f e c t i on by neut r a l i z e d  
H I V  on FOC ( Fi g  6 ) . I n  t he absence o f  FOC , H I V - 1  immune 
comp l e x e s  w e r e  unable to  i n f e c t  T ce l l s  rega rdl e s s  of t h e  
s t r a i n  o f  H I V- 1  u s e d . Howeve r ,  w h e n  FOC w e r e  p r e s en t , 
n e u t r a l i z e d  v i r u s  w a s  able  t o  i n fe c t  t h e  T ce l l s  indi c a t i n g  
t h a t  t h i s  FOC medi a t ed proce s s  was  not r e s t r i c ted t o  a s i ng l e  
a n t i body o r  H I V- 1 s t r a i n . I t  i s  
noteworthy  t h a t  t h e  l a b  i s o l a t e  S F2 ,  wh i c h  i s  e a s i l y  
neut r a l i z e d  b y  a n t ibody,  i s  rendered i n f e c t i ous  when FOC a r e  
p r e s en t . Thus  under condi t i ons when ant ibody i s  p a r t i c u l a r l y  
e f f i c i e n t  a t  n e u t ra l i z i ng v i r u s , FOC c a n  s t i l l  nega t e  i t s  
e f fe c t  sugge s t i ng t h a t  t h i s  FOC a c t i v i t y  i s  v e r y  p o t e n t . 
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F i g u r e  5 :  C u l t u r e s  o f  H I V- I I I B w i t h  neu t ra l i z i ng a n t ibody , 
human T c e l l s , and Human FDC were exami ned by e l e c t ron 
mi c ro s copy . La rge amoun t s  o f  virus  were ob s e rved budd i ng f rom 
t h e  p l a sma membrane . ( a ) ma gn i f i c a t ion 5 , 5 0 0 x ;  ( b )  1 6 , 8 0 0 x ;  
( c ) 5 2 , O O O x . 
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Figure 5 a  
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Figure 5 b  
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Figure 5 c  
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F i g u r e  6 :  FOC medi a t e d  i n f e c t ion by neut ra l i z e d  H I V- 1 immune 
c omp l e x e s  is not r e s t r i c t e d  to v i r a l  s t r a i n  o r  ant ibody . PCR 
a n a l ys i s  of H I V- 1  ga g provi r a l  DNA ( l l S bp ) and f) - g l ob i n  i n  
c u l t u r e s  con t a i n i n g  va r i o u s  s t ra i n s  o f  neu t r a l i z e d  H I V - 1  
immun e  c omp l e x e s  [ H I V - I C  ( F l O S ) ] and S E E  a c t i v a t e d  T ce l l s  
( T + S E E ) [ 2 .  6 x 1 0 4 ] o r  S E E  a c t ivated T ce l l s  and human F OC 
( 5 x 1 0 4 ) . I n f e c t i on by H I V - 1  immune comp l e x e s  formed w i t h  
human , neut ra l i z i ng a n t i - gp 1 2 0  ( l pg F 1 0 S  o r  2 0  mg I g G 1 b 1 2 ) w a s  
b l o c ked i n  t h e  absence o f  FOC w i t h  H I V - 1  s t ra i n s  1 1 1 8 ,  M N  and 
S F2 as reported ( ARRR P ,  Data Sheet ) and with the p r ima r y  s t ra i n  
3 0 1 7 1 4 . I n  cont ra s t , i n fect ion was  appa rent i n  c u l t u r e s  when 
FOC were p r e s en t  indicat ing that t he FOC ' s  ab i l i t y  t o  reve r s e  
t he e f f e c t  o f  neu t r a l i z i ng a n t i body was  n o t  r e s t r i c t e d  t o  a 
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Discussion 
H I V  i s  a c t i ve and prog r e s s i ve i n  s e c onda r y  l ymph o i d  
t i s s u e  du r i ng t he c l i n i c a l l y  l a t e n t  s t age o f  d i s e a s e . I n  
pa r t i cu l a r ,  H I V  i s  t r apped , a s  a r e  o t h e r  a n t i ge n s , o n  the  
dendr i t i c  proce s s e s  o f  FOC i n  t he form o f  immune comp l exe s . 
T h i s  t r apping involves  ant ibody , comp l eme n t , o r  bot h . S i nce 
t h e  ma j or s i t e o f  a c t i ve HIV i n f e c t ion t h roughout c l i n i c a l  
l a t e n c y  i s  t h e  g e rmi n a l  c e n t e r  s u r r ounding H I V  l aden F OC , we 
hypo t he s i z e d  t h a t  the  g e rminal center and FOC provide a unique 
e n v i r onme n t  which p l a ys a ma j o r role in  HIV i n f e c t i on . The 
obj e c t i ve of  t h i s  t he s i s  pro j e c t  was  t o  beg i n  t o  t e s t  t h i s  
hypot h e s i s  b y  det e rmining i f  H I V  immune comp l e x e s  o n  t h e  
s u r fa c e  o f  FOC were i n f e c t i ous . 
The resul t s  indicate that H I V  immune compl exes t rapped on 
t h e  s u r fa c e  of FOC a r e  h i gh l y  i n f e c t i ou s . H I V  immune c omp l e x  
f o rma t i on a n d  subs equent v i r u s  t r apping  o n  FOC w a s  p e r f o rmed 
in vi t ro ( f i gure 2 )  and in  vi vo ( f i gure 3 ) . FOC were washed t o  
r emove unbound v i ru s  a n d  then cult ured ( a s  t h e  onl y s ou r ce o f  
v i r u s ) w i t h  s u s c ept i b l e  C 0 4 + human T ce l l s . I n  both  s y s t ems 
i n f e c t i on was d e t e c t e d . Fu r t h e rmore , i n f e c t i o n  w a s  de t e c t ed 
even when H I V  immune comp l e x e s  were formed w i t h  p o t e n t  
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neut r a l i z i n g  ant ibody indicat ing that Foe were able  to  negate  
t h e  e f f e c t  o f  t h e  a n t ibod y ,  even when i t  was  present  i n  v a s t  
e x c e s s ( f i g u r e  4 a n d  5 ) . We be l i eve t h a t  t h e s e  r e s u l t s  wi l l  
h a v e  a s i gni f i ca n t  impa ct  o n  our unde r s t anding o f  H I V  
p a t hogene s i s ,  and i n t e rven t i on s t r a t e g i e s . 
I nfectivity of FOe trapped HIV 
Ou r f i r s t  experiment which t e s t ed the  i n f e c t i v i t y  o f  H I V  
t r apped on t h e  dend r i t i c  proce s s e s  o f  Foe ( Fi gu r e  2 )  mimi c ked 
i n  vi vo events i n  an  i n  vi t ro c u l t u r e  s y s t em .  We fo rmed H I V  
immune comp l e xe s ,  u s i n g  s e rum f r om an  H I V  i n fe c t ed i nd i v i du a l  
( a s  a s o u r c e  o f  a n t i body ) , a n d  t h e n  a l l owed t h e s e  t o  b e  
t r apped by Foe . Foe b e a r i ng H I V  were t h e n  cul tured w i t h  human 
T c e l l s  over  a f o u r  day p e r i od and prov i r a l  DNA was d e t e c t e d  
i n di c a t i n g  t h a t  t r apped v i r u s  was  s t i l l  i n f e c t i ou s . 
T o  mo r e  c l o s e l y  mimi c i n  vi vo condi t i on s , we r e p e a t e d  
t h i s  exper iment u s ing a xenogene i c  mode l ( mur ine ) whe re immune 
comp l e x  f o rma t i on and Foe l o c a l i z a t i on would occur  in vi vo . 
T h i s mode l o f  t r apping v i rus on mu r i n e  FOe w a s  p r omp t e d  b y  
p r e v i o u s  w o r k  u s i n g  convent i on a l  a n t i gen in  w h i c h  immu n i z a t i on 
o f  m i c e  w i t h  spe c i f i c  ant ibody f o l l owed by a n t i g e n  l e d  t o  
rapid immune complexes  forma t ion f o l l owed b y  F oe loca l i z a t i on . 
I n  o u r  s y s t em ,  we p a s s i v e l y  immun i z ed mice w i t h  a n t i - gp 1 2 0  
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f o l l owed by i n j  e c t i on o f  H I V . A f t e r  i n j  e c t i on o f  H I V ,  we 
w a i t e d  for f i ve days p r i or t o  i s o l a t i ng FOC . P r e v i o u s  
expe r ime n t s  w i t h  conve n t i o n a l  a n t i gen had s h own t h a t  b y  t h i s  
t ime ,  t h e  o n l y  a n t i gen rema i n i n g  i n  t he l ymph node w a s  t h a t  
t r apped b y  FOC . There fore , a f t e r  f i v e  days , mu r i ne FOC 
b e a r i ng H I V  were removed and c u l t u r e d  w i t h  human T c e l l s  a s  
previou s l y  done i n  f igure 2 .  Aga i n  i n fect ion w a s  c l e a r l y  seen 
i n d i c a t i n g  that  the  virus  rema i ned i n f e c t i ou s  ( Fi g u r e  3 )  . 
T h e  r e s u l t s  f rom the  mu r i n e  s t ud i e s  sugg e s t e d  t h a t  t h e  
envi ronmen t  t h a t  FOC provide i s  protect ive for  t h e  v i r u s . W e  
r e a s on t h a t  w i t h i n  t h e  mou s e , immune complex forma t ion and FOC 
l o ca l i z a t i on would occur in a s imi l a r  manner to  that  occu r r i ng 
i n  h uma n s . Howeve r , s i nce the  mou s e  l a c k s  c e l l s  b e a r i ng t h e  
human C 0 4  recepto r ,  the  vi rus cannot repl i c a t e . The r e fore , i n  
o u r  mu r i n e  mode l ,  t h e  vi rus w a s  able t o  rema i n  i n f e c t i o u s  for  
four  d a y s  before it  could come i n  c o n t a c t  with  s u s c ept i b l e  
c e l l s  t o  i n i t i a t e  v i r a l  rep l i ca t ion . T h i s  i s  p a r t i c u l a r l y  
s i g n i f i ca n t  when one con s i de r s  t h e  h a l f  l i fe o f  t h e  H I V  i n  t he 
absence o f  rep l i c a t i on . H I V  i s  e s t ima ted to  have a h a l f - l i fe 
o f  s i x  h o u r s  in  vi vo ( Ve rb a l  commu n i c a t i on - O .  H o ;  
I n t e rn a t i on a l  Cong r e s s  o f  Immunology Mee t i ng 7 / 9 5 ) . I n  o u r  
expe r i me n t , t h e  mice were i n j ected w i t h  2 5 , 0 0 0  TC I Oso , ( 5 0 0 0  
T C I Dso i n  each  o f  f i ve di f ferent  s i t e s ) . C a l cul a t i on s  based on 
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the s i x  hour  h a l f - l i fe wou l d  sugg e s t  t h a t  by the  end of t h e  
f i r s t  s i x  hou r s , 1 2 , 5 0 0  TC I 050 wou l d  rema i n  i n  t h e  mou s e . I n  
one d a y  ( i . e .  four h a l f - l ives ) ,  the amount o f  v i rus wou ld f a l l  
t o  3 , 1 2 5  T C I 050 and by t h e  end o f  t h e  four day expe riment , H I V  
wou l d  have unde rgone a decrea s e  o f  s i xteen h a l f  l i ve s . I f  a l l  
t h e  i n j e c t e d  v i rus we re t r apped o n  FOC and i f  e a c h  FOC b e a r i n g  
v i r u s  c o u l d  be i s o l a t ed t h i s  wou l d  i ndi c a t e  a max imum o f  6 
T C I 050 t h a t  c o u l d  be p r e s e n t  i n  the  en t i re mous e .  We f u r t h e r  
r e a s on t h a t  n o t  a l l  o f  the  i n j e c t e d  v i rus  wou l d  h a ve been 
t r apped by FOC and that  not all  FOC wou ld have been i s o l a t e d . 
T h u s , even t hough l i t t l e  i f  a n y  v i r u s  would be expected  t o  
r ema i n  i n  t h e  mou s e  f o r  f o u r  d a y s  i f  i t  w e r e  n o t  p r o t e c t e d  
f rom immune c l ea rance a n d / o r  inac t i va t i on , w e  saw subs t a n t i a l  
i n f e c t i o n  i n  o u r  c u l t u r e s ! T h e s e  d a t a  support t h e  h ypo t h e s i s  
t h a t  t h e  F OC t r apped v i rus  i s  i n f e c t i ou s  and t h a t  FOC c a n  
p r o t e c t  t h a t  i n f e c t i v i t y  beyond what wou l d  be expected t o  b e  
t h e  normal l i f e span o f  the virus . Thu s ,  we reason t h a t  F OC may 
p r o v i de a s ub s t a n t i a l  r e s e r v o i r  of i n f e c t i o u s  v i rus  t h a t  i s  
ma i n t a i n e d  f o r  long p e r i ods o f  t ime . 
T h e  envi ronme nt o f  the  g e rminal  c e n t e r  h a s  a u n i qu e  
c e l l u l a r  c ompo s i t i on w h i c h  i n f l uences  t he event s t h a t  o c c u r  
t h e r e . The p r e s ence o f  FOC and t h e i r  abi l i t y  t o  t rap a n t i gen 
is impo r t a n t  f o r  HIV because FOC s e rve a s  a r e s e r vo i r  f o r  
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v i r u s . A s  a rese rvoi r ,  FOC ma y protect t h e  v i r u s  from immune 
events  w h i c h  a t tempt t o  dest roy the  virus . C l ea rance o f  H I V  by 
the immune s y s t em is med i a t ed by a va r i e t y  o f  immune 
r e s p o n s e s . For examp l e ,  ce l l  med i a t e d  immu n i t y  i nc l uding  
c y t o t o x i c  HIV  s pe c i f i c  T c e l l s  appear  t o  p l a y  a s i g n i f i ca n t  
r o l e  i n  redu c i n g  vi remia during  t h e  a c u t e  pha s e  o f  t h e  
d i s e a s e . I n  add i t i on , a n  a n t ibody re spon s e  i s  mount e d  a g a i n s t  
t h e  v i r u s  wh i ch wou l d  f a c i l i t a t e  immune c l e a rance a s  we l l  a s  
f o l l i c u l a r  l o ca l i z a t i on . Ant i body may a l s o  r e s u l t  i n  
d e s t r uc t i on o f  i n f e c t e d  ce l l s  by a n t ibody depe ndent ce l l u l a r  
c y t o t ox i c i t y  ( AOCC ) medi a t e d  b y  n a t u r a l  k i l l e r  c e l l s  ( N K )  
F i na l l y ,  t he c omp l eme n t  pathways may a l s o  con t r i b u t e  t o  
d e c r e a s i ng v i r a l  l oad i n  v i  va . T h e s e  immune eve n t s  a nd 
p e r h a p s  o t h e r s  h e l p  r i d  the  body o f  c i r cu l a t i ng v i r u s . 
F u r t h e rmo re , F OC may a l s o  p r o t e c t  F OC t rapped immune 
comp l e x e s  w h i c h  c o u l d  poten t i a l l y  a c t i v a t e  c omp l eme n t  f r om 
d e s t r uc t i on v i a  a s  yet un known me c h a n i sms . We r e a s o n  t h a t  
c omp l emen t  a c t i va t i on by FOC t r apped H I V  immune comp l e x e s  
m i g h t  be p r e d i c t e d  t o  r e s u l t  i n  de s t ru c t i o n  o f  t h e  r e t a i ned 
a n t i ge n  a l on g  with the  FOC ne twor k .  Howeve r ,  s i nce a n t i gen ( i n 
the  f o rm o f  immune comp l ex ) i s  ma i n t a ined for l ong p e r i ods o f  
t ime , t h i s  suppo r t s  t h e  concept t h a t  FOC h a ve a mech a n i sm 
w h i c h  p r e ve n t s  comp l eme n t  l ys i s . Thus , FOC and the  ge rmi n a l  
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c e n t e r  app ea r  t o  provide a s a f e  s i t e  f o r  the  vi rus t o  r e s i de 
w i  t h o u t  b e i n g  a f f e c t e d  by the  immune s ys t em' s a t t empt s  a t  
c l e a ra n c e . 
I n  add i t i on to  providing a r e s e rvoir  s a fe f rom the  h a r s h  
e n v i r onme n t , F O C  m a y  a c t i ve l y  i n c r e a s e  i n f e c t i  vi t y  o f  t h e  
v i r u s  b y  f u r t h e r  a c t i v a t i n g  h e a l t h y  T ce l l s  and ma i n t a i n i n g  
t h e i r  v i a b i l i t y . S z a ka l ,  e t . a l . ,  found t h a t  a n t i ge n  t r apped 
on  FOC w i t h i n  a g e rmi n a l  c e n t e r  was  not  ra ndoml y r e t a i ned on  
F OC b u t  that  a g i ven a n t i gen was  t rapped on a s i n g l e  FOC 
netwo r k  in a h i g h l y  ordered periodic fa s h i on . Fu r t h e rmore , i t  
w a s  obse rved t h a t  one g e rmi n a l  center  could have mor e  t h a n  one 
a n t i g e n  r e t a i n i n g  FOC ne twor k .  In t h i s  f a s h i on , ge rmi n a l  
c e n t e r s  wou ld h a ve di f f e re n t  a n t i ge n i c  spe c i f i c i t i e s  and 
s e v e r a l  a n t i ge n s  could be found i n  one  fol l i c l e  ( unpub l i s h e d )  
[ 1 2 1 , 1 2 2 ] . T h e r e fore , w e  r e a s oned t h a t  w i t h i n  a l ymph node 
there are s ome ge rmi n a l  cent e r s  with FOC t r apped H I V  and s ome 
w i t ho u t  depend i n g  on the  s t a ge o f  d i s e a s e  and the  amount  o f  
v i r u s  b e i ng produced . We f u r t h e r  envi s i on t h a t  b o t h  t yp e s  o f  
g e rmi n a l  c e n t e r s  wou l d  p l a y a role  in  i ncrea s i ng i n fe c t i on a n d  
ma i n t a i n i n g  c e l l  v i a b i l i t y . H I V  i n f e c t e d  i n d i v i du a l s  h a ve 
C 0 4 + T h e l p e r  ce l l s  w h i c h  a r e  both n o n i n fected  and l a t e n t l y  
i n f e c t e d  ( i . e . , ha rbor provi r a l  ONA ) C e l l s  f rom e i th e r  group 
ma y be spe c i f i c  for  H I V  o r  another  a n t i gen . As t h e  c e l l s  
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e n t e r  v a r i o u s  g e rminal  cente r s , t h e y  may become a c t i v a t e d  a s  
t h e y  i n t e ra c t  w i t h  a n t i gen present i ng ce l l s  a t  t h a t  s i t e . Once 
a c t i v a t e d ,  they may r e c e i ve a c o s t i mu l a t o r y  s i gn a l  f r om Foe . 
Foe have been shown to  p rovide cost imu l a tory s i g na l i ng t o  both 
T a nd B ce l l s  which r e s u l t s  i n  ma r ked i n c r e a s e  in  
p r o l i f e r a t i o n  [ 1 3 1 , 1 4 7 )  . 
We e n v i s i on t h r e e  u n i que s c e n a r i o ' s i n  t h e  l ymph nodes 
of  HIV i n fected i ndividua l s . Firs t ,  a non - i n fected T cell  can  
e n t e r  a g e rmi n a l  center  with  virus  l aden Foe . T h i s c e l l ,  
speci f i c  for  another a n t i g e n ,  ma y become act i va t ed by B c e l l s  
p r e s en t i ng t h a t  a n t i gen . I t  c a n  then r e c e i v e  cos t imu l a t o r y  
s i g na l s  f rom FOe , become f u l l y  a c t i va t e d ,  a n d  p r o l i f e r a t e . 
Once i n  the  a c t i v a t ed s t a t e , the c e l l  i s  h i g h l y  s u s cept i b l e  t o  
i n f e c t i o n  by t he H I V  t r apped on Foe . T h e  s e cond s c e n a r i o  
i nv o l ve s l a t e n t l y  i n f e c t e d  c e l l s  e n t e r i ng g e rmi n a l  c e n t e r s  
w i t h  Foe l a c ki n g  H I V  on the i r  proce s s e s . I n  t h i s  environment ,  
t h e  c e l l  c a n  a g a i n  be a c t i va t e d  by B c e l l s  p r e s e n t i n g  t h e  
r e q u i red s pe c i f i c  a n t i gen f o l l owed by co s t imu l a t i o n  b y  Foe . 
Once f u l l y  a c t i va t e d ,  t he i n f e c t e d  c e l l  w i l l  beg i n  a c t i ve 
r e p l i c a t i on o f  H I V  a nd wi l l  p ro l i fe r a t e  t h e r eb y  i nc r e a s i ng 
v i r a l  l o a d . Fina l l y ,  i n  the  l a s t  s c e n a r i o ,  H I V  spe c i f i c  
l a t e n t l y  i n fe c t ed c e l l s  e n t e r  a ge rmi n a l  center  w i t h  H I V  l aden 
Foe . T h e s e  ce l l s  w i l l  i n t e r a c t  w i t h  proce s s ed a n t i g e n  
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expre s s ed on B c e l l s  and w i l l  a l s o  receive Foe cost imul a t i on . 
As b e f o r e , t h e y  w i l l  prol i fe r a t e  and rep l i c a t e  v i r u s . I n  
addi t i o n ,  t h e s e  c e l l s  wi l l  b e  s u s cept ible  to  supe r i n f e c t i o n  by 
the H I V  t rapped on Foe . I n  a l l  o f  t h e s e  s i t u a t i on s ,  Foe a nd 
t h e i r  c o s t imu l a t o r y  s i g n a l s  a r e  a c t i va t i ng T ce l l s ,  c a u s i ng 
i n c r e a s e d  p r o l i f e r a t ion , i nc r e a s i n g  s u s ceptibi l i t y  t o  H I V ,  and 
u l t ima t e l y  c on t r i but i ng t o  the  overa l l  i n f e c t i o n . 
I n  addi t i o n  t o  a c t i va t i ng c e l l s  a nd c a u s i n g  
Foe a r e  a l s o  a b l e  t o  ma i n t a i n  c e l l  p r o l i fe r a t i on ,  
v i ab i l i t y [ 1 4 7 J . I n  previous  wo r k ,  c u l t u r e s  o f  B ce l l s  
s t imu l a t e d  w i t h  a n t i - � a nd I L - 4  ± Foe both s howed i n c r e a s e d  
prol i fe r a t i on . Those c u l t u r e s  w i t h  Foe h a d  a three - fo l d  h i g h e r  
p r o l i f e r a t i ve r e sponse . A l o n g  w i t h  t h i s ,  F o e  w e r e  a b l e  t o  
ma i n t a i n  p r o l i f e r a t i on f o r  s e ve r a l  days . Whi l e  c u l t u r e s  o f  B 
ce l l s  a l one had l i t t l e  o r  no detectable prol i f e ra t i on a f t e r  4 
d a y s , t h o s e  con t a i n i n g  Foe ma i n t a i ned p r o l i f e r a t i on . 
Fu r t h e rmo r e , e x ami n a t ion by t r ypan b l u e  e x c l u s i on i n d i c a t e d  
t h a t  a f t e r  3 d a y s  only  2 4 %  o f  the  c e l l s  we re v i a b l e  i n  B c e l l  
c u l t u re s  a l one whe r e a s  n e a r l y  1 0 0 %  w e r e  v i a b l e  i n  c u l t u r e s  
cont a i n i n g  Foe . T h e  abi l i t y  o f  Foe to n o t  on l y  i n c r e a s e  c e l l  
p r o l i f e r a t i on b u t  a l s o  ma i n t a i n  v i ab i l i t y may con t r ib u t e  t o  
t h e  ma i nt e n a nce o f  H I V  i n fe c t i o n  w i  t h i n  ge rmi n a l  c e n t e r s  
du r i n g  c l i n i c a l  l a t ency . 
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T h e  ma i n t e nance  o f  c e l l v i a bi l i t y  may i n  p a r t  be 
a t t r ib u t a b l e  to  t h e  ab i l i t y  o f  FOC to  d e c r e a s e  apop t o s i s  
( X i on g  & Tew unpub l i s hed ) . I n  s imi l a r  exper ime n t s , m i t o g e n  
s t i mu l a t e d  B c e l l s  were  c u l t u r e d  w i t h  F O C  o r  redu c i n g  a g e n t s  
s u c h  a s  t h i o l s  to  f u r t h e r  chara c t e r i z e  the  c o s t imu l a t o r y  
e f fe c t . B o t h  s h owed a ugment a t i on o f  prol i f e r a t i on above 
m i t o g e n  s t imu l a t i on a l one . Fu r t hermore , t h i o l s  i nduced 
s i g n i f i c a n t l y  higher l e ve l s  o f  prol i f e ra t i on above that s e e n  
w i  t h  FOC . A f t e r  s even d a y s  o f  cul t u r e , c e l l v i ab i l i t y  w a s  
e x amined b y  micros cop i c  a n a l y s i s .  W h i l e  c u l t u r e s  cont a i n i n g  
FOC r ema i ned h e a l t h y  a n d  vi abl e ,  those  w i t h  t h i o l s  h a d  f e w  i f  
a n y  h e a l t h y  ce l l s  l e f t  . T h i o l s  were  a b l e  t o  i nduce 
p r o l i f e r a t i on but  c u l t u r e s  were h i g h l y  apop t o t i c . FOC 
c on t a i n i n g  c u l t u r e s , on t he o t h e r  h a n d ,  had l ow e r  l e v e l s  o f  
apop t ot i c  ce l l s . 
T o  f u r t h e r  e l u c i d a t e  t h i s  phenomenon , B ce l l s  a nd a n t i ­
f a s  a n t i body w e r e  c u l t ured w i t h  o r  w i t hout  FOC ( Xi ong & Tew 
unpub l i s h ed ) . In  cultures w i t hout FOC , f a s  med i a t e d  apoptos i s  
occur red a t  a h i g h  frequency a s  expected . Howeve r ,  i n  c u l t u r e s  
w i t h  FOC , apop t o t i c  l e ve l s  w e r e  g r e a t l y  de c r e a s e d  s u gg e s t i ng 
t h a t  FOC , and mi croenvi ronment they p rovide , spare c e l l s  f rom 
de a t h . We be l i eve that  FOC ma y prevent apoptos i s  in g e rmi n a l  
c e n t e r  T ce l l s  i n  a s imi l a r  manne r .  
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R e c e n t  s t ud i e s  b y  Kup f e r  e t . al . examined apop t o s i s  i n  
H I V  i n f e c t i on b y  doub l e  s t a i n ing immuno h i s tochemi s t r y [ 1 5 7 ) . 
U s i n g  one s t a i n  f o r  H I V  RNA and another  for  apopt o s i s ,  they  
found t h a t  i n  t he l ymph node those  cells  unde rgoing apop t o s i s  
were " i n  no c a s e u  produ c t i v e l y  i n fected ( i . e .  expre s s i ng v i r a l  
me s s a ge ) . T h e y  hypothe s i zed t h a t  H I V  i n fected T cel l s  e xp r e s s  
a v i r a l l y  encoded p r o t e i n  w h i c h  prevents  apop t o s i s . W e  
e n t e r t a i n  a n o t h e r  hypothe s i s  envi s i on i ng that  T ce l l s ,  a s  they  
i n t e r a c t  with  FOC , not o n l y  become i n fe c t e d  with  FOC t r apped 
H I V  but  a l s o  r e c e i v e  s i gna l s  f r om F OC spa r i ng t hem f r om 
apop t o s i s . I f  FOC a re able t o  spa re ce l l s ,  s ome o f  w h i c h  a r e  
i n f e c t e d ,  t h e y  may b e  inadve r tent l y  ma i n t a ining  i n f e c t ion . B y  
ma i n t a i n i ng an  envi ronme nt which s a v e s  c e l l s  and i nduces  
prol i f e r a t i o n ,  FOC  may  be increas ing v i r a l  load o f  infected T 
c e l l s  w i t h i n  t h e  g e rminal  cent e r . 
Negati on of neutraliz ing antibody by FOC 
The s e cond ma j or f i nding  of our wo r k  i s  t h a t  F OC c a n  
n e g a t e  the  e f fe c t  o f  neut r a l i z i ng ant ibod i e s . I n  our s t udi e s , 
t h e  v i r u s  w a s  incubated w i t h  severa l dos e s  o f  neut r a l i z i ng 
a n t i body ranging f r om one nanogram ( ng )  to  one  mi l l i g ram ( mg ) . 
At a l l  d o s e s  o f  neu t r a l i z i n g  ant ibody , the  v i r u s  was  unable t o  
c a u s e  i n fe c t ion when c u l t ured w i t h  a c t i va ted T c e l l s  ve r i f y i ng 
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t h a t  the  virus  was f u l l y  neut r a l i zed . Howeve r ,  when FDC were 
added t o  the  c u l t u re s ,  in fection was detected indi c a t i n g  t h a t  
F D C  were able  t o  r ender the neut r a l i zed immune comp l e x  i n t o  an  
i n f e c t ious  form . T h i s  phe nomenon was not re s t r i c t e d  by v i r a l  
s t ra i n  o r  a n t i body ( f igure  6 ) . 
T h e s e  exper ime n t s  u t i l i z ed a wide r a nge o f  neut r a l i z i ng 
ant i body dos e s  ( Figure 4 ) . At t h i s  l owe s t  neutra l i z i n g  dos e ,  
1 n a no g r am o f  neut r a l i z i ng ant ibody , a l l  o f  t he v i r u s  w a s  
n e u t r a l i z e d . I n  t h e  p r e s ence o f  F D C  the  s i gn a l  w a s  v e r y  
i n t e n s e  indicat ing high  l e ve l s  o f  i n f e c t i on . T h i s  impre s s i ve 
r e s po n s e  w a s  seen  i n  a l l  t h r e e  c u l t u r e s  o f  t h i s  s amp l e .  
Fu r t h e rmore , t he s i gnal was  much more intense  than t h a t  o f  the  
pos i t i ve c o n t r o l  ACH - 2  con t a i n i n g  5 0 , 0 0 0  ce l l s  e a c h  with  one 
copy o f  provi r a l  DNA . T h i s  i ndi c a t e s  t h a t  FDC w e r e  a b l e  t o  
t a ke ful l y  neut r a l i zed v i r a l  immune comp l ex e s  a n d  rende r them 
h i g h l y  i n f e c t i ous such that infect i on / integra t i on occurred in 
g r e a t e r  t han 5 0 , 0 0 0  ce l l s . 
A l t hough t h e  i n t e n s i t y  o f  the  s i gna l was  de c r e a s e d  
cons i d e r a b l y  when I J..lg o r  1 mg o f  a n t ibody was  p r e s e n t , t h e  
s i gn a l  w a s  s t i l l  app a r ent  i nd i c a t i n g  t h a t  neut ra l i z i n g  
a n t i body when p r e s e n t  i n  va s t  exce s s  could n o t  p revent 
i n f e c t i on . Mi l l i g ram l e ve l s  o f  neut ra l i z ing ant ibody a r e  not  
found n a t u r a l l y  i n  infected i nd i v i dua l s  but we wanted  t o  
8 2  
de t e rmine i f  there w a s  a threshold level a t  which the  e f f e c t s  
o f  FOC w o u l d  be l o s t . M i l l i g ram l e ve l s  o f  a n t i body d i d  not 
a ch i eve t h i s . FOC were s t i l l  able to nega te  the e f fect  o f  the  
a n t ibody . 
Al t hough F OC i n  our s y s tem a r e  a b l e  t o  ne g a t e  t h e  
e f f e c t s  o f  t h e  n e u t r a l i z i ng ant ibody i n  a l l  c a s e s  s h own , o u r  
d a t a  a l s o  s ugg e s t s  t h a t  i n c r e a s i ng t i t e r s  o f  n e u t r a l i z i ng 
a n t ibody a r e  bene f i c i a l . F i g u r e  4 s h ows decrea s i ng s i g n a l  
repre s e n t a t i ve o f  H I V  i n fect i on i n  t he pre sence o f  i n c r e a s i n g  
d o s e s  o f  neut ra l i z i ng a n t i body . T h i s  s ugge s t s  t h a t  h i gh 
l e ve l s  o f  a n t i body ma y dampen t he v i r a l  load i n  i n d i v i du a l s  
i n f e c t ed w i t h  t h e  v i r u s . 
T h e  ab i l i ty  o f  FOC t o  fa c i l i t a t e  H I V  i n f e c t i on i n  t h e  
p r e s e n c e  o f  neu t r a l i z i ng a n t i body m a y  help  to  e xpl a i n  t h e  
rea son s ome i nd i v idua l s  w i t h  h i gh t i t e r  neut ra l i z i ng a n t i body 
h a ve ongoing  i n f e c t i on . I t  may a l s o  h e l p  expl a i n  t h e  r e a s on 
t h a t  much o f  the  v i r a l  repl i c a t i on o c c u r r i n g  dur i ng t h e  
c l i n i c a l l y  l a t e nt  s t a ge o f  H I V  i n f e c t i on i s  c o n f i ned t o  
l ymph o i d  f o l l i c l e s  whe re vi r u s  laden FOC r e s i de i n  i n t ima t e  
con t a c t  w i t h  g e rmi n a l  center  T and B c e l l s .  Al t h ough t h e  
me chan i sm conve r t i ng neu t r a l i zed v i r u s  into an i n f e c t i ous  form 
by FOC i s  un c l e a r ,  t h e r e  a r e  s i mi l a r i t i e s  to  event s w h i c h  
o c c u r  i n  anamne s t i c  re spons e s  where a n t i gens  a r e t rapped b y  
FDC i n  t h e  f o rm o f  immune comp l ex e s . 
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Even t h ough a n t ibody 
s h o u l d  "ma s k " epi t opes  and prevent recogn i t i on by t h e  
immu n o g l obu l i n  recept o r s  o f  B c e l l s , exper imen t s  h a ve s h own 
t h a t  a n t i gen- spec i f i c  B c e l l s  a re able to recogni ze  t he immune 
c omp l e x e d  a n t i gen in va s t  a n t i body exce s s [ 1 5 8 , 1 5 9 )  We 
envi s i on a s imi l a r  proce s s  i n  t h e  case o f  FDC t r a pped H I V .  
The V 3  l oop o f  H I V - l  gp 1 6 0 would be potent i a l l y  "ma s ked" b y  
n e u t r a l i z i n g  a n t i body but t he F D C  can  di s p l a y  the  v i r u s  i n  a 
m a n n e r  t h a t  gp 1 2 0  c a n  b i n d  C D 4  on adj a cent  T c e l l s  and t h u s  
c a u s e  i n fect ion . T h e  f i nding that  FDC can  conve r t  neu t ra l i z ed 
H I V  immune c omp l e x e s  i n t o  an i n fe c t i ou s  form ma y h a ve 
imp o r t a n t  imp l i c a t i on s  for  the  d e s i g n  o f  t he r a peu t i c  and 
vaccine s t r a t e g i e s , r e g a r dl e s s  o f  t he me chan i sm ( s )  i n v o l ve d . 
Neutraliz ati on As s ays 
Curren t l y  there are t h ree ma i n  protocol s for  r e s e a rching  
neut r a l i z a t ion o f  H I V . Common i n  vi t ro me t hods culture  v i r u s , 
n e u t r a l i z i ng a n t ibody , and s u s c ept i b l e  T ce l l s  p r i o r  t o  
a s s a y i ng f o r  v i r a l  i nt e g r a t i on and/or  p 2 4  l e ve l s . I n fe c t i v i t y  
c a n  b e  mea sured by a s s a ying for  integrated prov i r a l  DNA u s i ng 
PCR a n a l y s i s  a s  u s e d  i n  t h e s e  s t u di e s . P r ime r s  spe c i f i c  f o r  
gag a r e  c h o s e n  s i n c e  gag i s  among the l a s t  p a r t  o f  t h e  genome 
t r a n s c r i bed p r i o r  to i n t e g r a t i on . De t e c t i on o f  gag u s ua l l y  
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i nd i c a t e s  t h a t  a f u l l  provi rus h a s  been integrated . The o t h e r  
me thod a s s a y s  for  the  pre sence o f  p 2 4  in  culture  superna t a n t s  
b y  E L I SA . P 2 4  c a n  be d i r e c t l y  c o r re l a t ed to  in f e c t i v i t y  but 
t h i s  va l ue may mis represent i n f e c t i v i t y  s i nce p2 4 can a l s o  be 
gene r a t ed f rom de f e c t i ve virus pa r t i c l e s . 
T h e  mo s t  recent  i n  v i vo model generated  t o  s t udy H I V  
p a t hogen e s i s  i s  t h e  h u - H I V  / PB L - S C I O  mou s e  [ 1 5 7 ]  . T h e  S C I O 
mou s e  l a c k s  mu r i n e  T and B ce l l s  and ma t u r e  FOC . I n  t h e  h u ­
H I V / S C I O mod e l , mice  a r e  engra f t e d  w i t h  human PBL a n d  
t h e r e f o r e  c a n  ma i n t a i n  H I V  i n f e c t i on and repl i c a t i o n . The 
advan t a g e  o f  this s y s t em is  the pre sence o f  the  characte r i s t i c  
C 0 4 + T c e l l  dep l e t i on dur i ng a c t i ve i n f e c t i on . T h i s  mod e l  h a s  
b e e n  ut i l i z e d  t o  s t udy s ome t h e r ap i e s  i nc l ud i n g  a n t i - v i r a l  
a g e n t s  s u c h  a s  n u c l e o s i de a n a l o g s . S t u d i e s  u s i ng t h i s  mode l 
and t r e a tment demon s t rated i n c r e a s e s  i n  c i r cu l a t i ng T ce l l s  i n  
vi vo . T h i s  model i s  expected t o  b e  a u s e f u l  technique f o r  the  
s t udy of n e u t r a l i z i ng a n t i body and o t h e r  poten t i a l l y  
bene f i c i a l  t he r a p i e s . 
The above described protocol s neglect to  addre s s  the  role  
of  FOC and t h e  g e rm i n a l  cent e r . Our a s s a y  demon s t r a t ed 
e f f e c t i ve neut r a l i z a t i o n  i n  the  absence o f  F OC ye t i n  t h e i r  
pres ence e f fe c t i ve neut r a l i z a t i on was not obs e rved . S i n c e  FOC 
app e a r  to have an  imp o r t a n t  r o l e  in the ma i nt enance of H I V  
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i n f e c t i on , p r o t oc o l s  mu s t  i n c l ude a n  a c c u r a t e  r e p r e s e n t a t ion 
of  i n  vi vo condi t i ons , i nc l uding g e rminal cen t e r s  with  FOC , a s  
o u r  i n  v i  v a  and i n  v i  t ro mode l s  do . C u l t u r i ng � n  vi t ro 
s y s t ems w i t h  and w i t hout FOC w i l l  a l l ow r e s e a rchers  t o  addre s s  
a l l  a s p e c t s  o f  d i s e a s e  s t a g e s . In vi vo me t hodo l og i e s  mu s t  
a l s o  n o t  e x c l ude t h e  pot ent i a l  r o l e  o f  FOC . Mod e l s  l i ke t h e  
h u - H I V / PB L - SC I O  do not a c c u ra t e l y  repre s e n t  i n  vi vo 
condi t i o n s . Fu r t h e rmore , recon s t i t u t i on o f  human l ymph node s 
w i t h  g e rmi n a l  cen t e r s  and f u n c t i o n a l  FOC i s  n e a r  impo s s i b l e  
( pe r sonal  commu n i c a t i o n ,  M .  Connners ) .  Wi thout addre s s i n g  the  
role  of  FOC t h e  r e s e a rch neglects  many o f  the  event s 
s u r rounding the  l a t e acute s t age , a l l  o f  the c l i n i ca l l y  l a t e n t  
s t age , and much o f  AI DS . A f u l l  unde r s t anding o f  pa thogen e s i s  
r e qu i re s  a n  unde r s t anding o f  t h e s e  even t s . 
Vaccination S trategies 
We b e l i eve t h e  d a t a  p r e s e nted h e r e  may a l s o  c a u s e  u s  t o  
r e shape ou r t h i n k i n g  o f  c u r r e n t  va c c i n a t i on s t r a t e g i e s .  When  
deve l o p i n g  a v a c c i n e  a g a i n s t  a n y  m i c r ob i a l  a g e n t  one o f  t h e  
f i r s t  que s t i ons  a s ked i s : W h i c h  immune re spon s e  mechani sms a r e  
p r o t e c t i ve ?  T h i s knowledge i s  fundame n t a l  i n  t h e  e n g i n e e r i ng 
o f  v a c c i ne s . Vaccines  a t t empt to  pr ime the immune response s o  
t h a t  subs equent exposure to  the  organi sm wi l l  r e s u l t  i n  a more 
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r a p i d  v i go r o u s  re spons e .  Not only do we not know w h i c h  
r e spon s e  a re protect ive , but w e  a l s o  do not k n o w  wh i ch 
r e spon s e s  prevent s eque s t ra t i on o f  the  v i r u s  w h i c h  p r e f a c e s  
c l i n i c a l  l a t e n c y . M o r e  r e s e a rch o n  the  p a t hoge n e s i s  o f  H I V  
w i l l  b r i ng u s  c l o s e r  to  an swe r i ng t h e s e  que s t i on s . 
C u r rent vac c i n a t i on a t t empt s  focus prima r i l y  on b l oc k i ng 
v i r a l  e n t r y  i n t o  s u s ceptible  c e l l s  by e l i c i t i ng an ant i - gp 1 2 0  
a n t i body r e spon s e . I n  f a c t , the  f i r s t  t e s t ed v a c c i n e  w a s  
r e c omb i n a n t  gp 1 2 0  w h i c h  a t t empt e d  ant ibody med i a t ed 
prevent i on . None o f  t h e s e  t r i a l s  were succe s s fu l . S i nce t h e n ,  
gp 1 2 0  h a s  b e e n  mapped a n d  humo r a l  e p i t op e s  h a ve been  
d e t e rmined . Many  researchers  a r e  now foc u s i ng on one  a r e a , the  
V - 3  l oop , which cont a i n s  a neu t r a l i z i ng doma i n . Many p a t i e n t s  
p r oduce h i g h l e v e l s  o f  n e u t r a l i z i n g  a n t i body yet i n f e c t i o n  
p e r s i s t s . F u r t h e rmore , t h e r e  i s  no s o l i d  c o r re l a t i on b e t w e e n  
neut ra l i z i ng ant ibody t i te r s  a n d  d i s e a s e  progre s s i on . An t i body 
r e s p o n s e s  norma l l y  prevent v i r a l  i n f e c t i on . Howeve r ,  d a t a  
p r e s e n t e d  here  demo n s t r a t e s  that  v i r a l - a n t ibody comp l e x e s  a r e  
s t i l l  i n f e c t i ou s , e v e n  i n  the  p r e s ence o f  h i g h  l e v e l s  o f  
n e u t r a l i z i n g  a n t ibody . V a c c i n e s  w h i c h  a t t empt t o  e l i c i t  a 
s t rong a n t i body response  t h e r e f o r e  may provide l i t t l e  o r  n o  
p r ot e c t i on . 
S ome v a c c i n e s  not only  f a i l  t o  p r o t e c t  but  a l s o  enhance 
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d i s e a s e . T h i s  h a s  been the c a s e  i n  several  d i s e a s e s  i n c l uding 
r e s p i r a t o r y  s yncyt i a l  virus and mea s l e s  i n  huma n s . I n  
addi t i o n , o t h e r  l e n t i v i r u s e s  have shown t h i s  feature i n c luding  
a r t h r i t i s - enc epha l i t i s  virus i n  goa t s  and v i s n a -maedi v i r u s  in  
s h e ep ( 1 6 0 ) . A v a c c i n e  for  HIV  w h i c h  e l i c i t s  a n  a n t ibody 
r e s p on s e  ma y a l s o  r e s u l t  i n  enhancing  i n f e c t i on . S ome people  
who are  exposed t o  HIV  fail  t o  become i n f e c t e d . Cytotoxic  T 
l ymphocy t e s  and compl ement mechani sms a r e  the  f i r s t  re spon s e s  
t o  H I V  known t o  c l e a r  t h e  i n i t i a l  vi remi a . I t  i s  c on c e i va b l e  
t h a t  s ome peop l e  a r e  a b l e  t o  c l e a r  the  v i ru s  qu i c k l y  be fore  i t  
b e c ome s t rapped on t h e  FOC . I f  vacc i n a t i on w h i c h  e l i c i t e d  
c i r c u l a t i n g  a n t ibodi e s  a g a i n s t  H I V  were a va i l ab l e ,  i t  i s  
pos s i b l e  t h a t  mo r e  people wou l d  become i n f e c t e d  a f t e r  
expos u r e . T h e  c i r c u l a t i n g  a n t ibod i e s  wou l d  become comp l exed 
w i  t h  t h e  virus  a nd would qu i c k l y  be c a r r i ed t o  t h e  mo s t  
p r ox imal  l ymph node . H e r e  t h e  v i r a l  comp l e x  wou ld b e  t rapped 
on FOC and be r e t a i ned for  several yea r s . The virus wou l d  be 
i n  a envi ronment which ma kes i t  more immunoge n i c  and b r i n g s  i t  
c l o s e  t o  h i g h l y  a c t i va t e d  C 0 4 + T ce l l s . The long t e rm s l ow 
progre s s i ve d i s e a s e  would begi n . 
R a t h e r  t h a n  e n g i n e e r  v a c c i n e s  t o  e l i c i t  a n  a n t ibody 
r e spon s e , we b e l i e ve that a CMI r e s pon s e  wou l d  be mo r e  
prot e c t i ve i n  l i ght o f  the  data  p r e s e n t e d  here . As p r e vi ou s l y  
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s t a t e d ,  t h e  de s i gn o f  vacc i n e s  should a t temp t t o  mimi c t h e  
n a t u r a l  immune re spon s e  which res u l t s  in  protec t i on . T h e  f i r s t  
r e s pon s e s  which occur i n  H I V  i n fection a r e  C O B  l ymphocyte and 
comp l emen t  mediated  eve n t s . A l t hough t h e s e  re spon s e s  a r e  not 
who l l y  protect ive , they are succe s s ful  a t  c l e a r i n g  t he i n i t i a l  
vi r emi a . 
Addi t i on a l  d a t a  a l s o  supp o r t s  t he hypot he s i s  t h a t  t h e  
c e l l u l a r  immune r e s p o n s e  i s  p r o t e c t i ve . H I V- s pe c i f i c  T c e l l  
r e spon s e s  have been d e t e c t ed i n  huma n a n d  a n i ma l s  who h a ve 
b e e n  mu l t ip l y  exposed to  H I V  o r  S I V ,  respec t i vel y .  S e v e r a l  
h i gh r i s k  o r  H I V  exposed popu l a t i o n s  h a ve been s t ud i e d  
i n c l u d i n g  g a y  me n ,  i n t r avenous drug u s e r s ,  a c c i d e n t a l l y  
e x p o s e d  h e a l t h  worke r s , and newborns  o f  H I V  i n f e c t ed 
mot h e r s  [ 1 6 1 - 1 6 3 ]  ( P i n t o ;  manuscript  submi t t ed for  publ i c a t ion ) . 
PBMC f rom t h e s e  peop l e  were cha l l enged w i t h  H I V  e n ve l ope 
s yn t he t i c  pept i d e s . I n  t he g r oup s , 3 5 %  t o  7 5 %  o f  t h e  
i ndi vidua l s  responded to  a t  l e a s t  t w o  o f  the  f i ve pep t i d e s  a s  
compa red t o  con t r o l s  w h i c h  re sponded 0 - 2 % . M o r e  recent l y ,  C D B + 
CTL ' s speci f i c  for  NEF were detected i n  women p a r t n e r s  o f  H I V+ 
me n [ 1 6 4 ] . S t u d i e s  u s i n g  t h e  an ima l model S I V  i n  ma c a qu e s  
demon s t r a t e s  t h a t  l ow dose exposure i nduces a c e l l u l a r  
response  b u t  n o t  a hume r a l  respon s e . L a t e r  cha l l enge w i t h  S I V  
r e s u l t e d  i n  s t rong T p r o l i f e r a t ive r e spon s e s , n o  
8 9  
s e r oconve r s i o n ,  n o  detectable provi rus by PCR a n a l ys i s ,  and no 
d i s e a s e  whereas  control s ,  not recei ving t he s ubi n fe c t ious  dose 
p r e v i ou s l y ,  d i d  s e roconve r t  and develop d i s e a s e [ 1 6 5 ] . 
I n  a ddi t i on ,  s ome c e l l  med i a t e d  a c t i v i t i e s  h a ve been 
c o r r e l a t e d  w i t h  a pos i t i ve prognos i s . Long t e rm s u r v i va l  h a s  
r e c e n t l y  b e e n  a s s o c i a t ed w i t h  a s t rong c e l l u l a r  immune 
response  cha r a c t e r i zed by a n t i - H I V  supp r e s s o r  a c t i v i t i e s  [ 1 6 6 ]  . 
T h i s  supp r e s s o r  a c t i v i t y  i s  b e l i e ved t o  p r e v e n t  v i r a l  
r ep l i c a t i on a n d  v i r a l  expre s s ion . Fur t h e rmore , i t  ma y prevent 
s ome o f  t h e  h a rmful  CTL respon s e s . T h e s e  fun c t i on s  ma y be 
i mpo r t a n t  i n  ma i n t a i n i n g  v i r o l o g i c a l  l a t e n c y  a nd t he reby 
a l l ow i n g  n o rmal T cell  func t i on . T h e s e  d a t a  and our  r e s u l t s  
suppor t  the  hypothe s i s  that  a c e l l u l a r  re spon s e  i s  p r o t e c t ive 
and t h a t  v a cc i n a t i on s  should be e n g i n e e r e d  t o  e l i c i t  a 
c e l l u l a r  r e spon s e  a s  oppo sed t o  a humo r a l  r e sponse . 
Treatment Strategies 
W e  be l i eve the  d a t a  p r e s e n t e d  h e r e  w i l l  a l s o be ne f i t  
t ho s e  a l ready i n f e c t e d  w i t h  H I V  a s  i t  may r e s t r u c t u r e  
t r e a tmen t  s t rategi e s . Although the  immune respon s e  u l t ima t e l y  
f a i l s  a t  d e f e a t i n g  t h e  v i rus , i t  i s  e f f e c t i ve a t  ma i n t a i n i n g  
l ow v i remi a l e ve l s  f o r  several  yea r s . T h e  a n t i body response  i s  
be l i eved t o  con t r ibute b o t h  t o  t h e  i n i t i a l  c l e a r i n g  o f  t h e  
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v i r u s  a n d  t o  t h e  ma i n t enance o f  l ow p l a sma v i r u s  l e ve l s  
t h roughout c l i n i c a l  l a tency . The repe r t o i r e o f  a n t ibod i e s  
w h i c h  e x i s t  o f t e n i n c l udes neut r a l i z i n g  a n t i bodi e s . 
Neut r a l i z ing ant ibodi e s  a r e  u s u a l l y  detectable w i t h i n  one year 
of the acute pha s e [ 1 6 7 , 1 6 8 ] . Al though h i g h  t i t e r s  o f  
neut r a l i z i n g  ant ibody d o  not correlate  with  prevent ion o f  AI DS 
and d e a t h  [ 1 6 9 ] , s ome r e s e a r c h e r s  h a ve cor r e l a t ed t hem w i t h  
good s h o r t  t e rm prognos i s [ 1 7 0 ] . Fu r t h e rmore , i n fected mot h e r s  
who d i d  not t r a n smi t the  v i r u s  t o  t h e i r  bab i e s  were  reported 
t o  h a ve b e t t e r  n e u t r a l i z ing capab i l i t i e s [ 1 7 1 - 1 7 4 ] . T h i s  
s u gge s t s  t h a t  t h e  ant ibody r e sponse doe s p l a y  a bene f i c i a l  
r o l e . I n  a dd i t i on t o  t h i s , o u r  d a t a  a l s o  s ugge s t  t h a t  
i n c r e a s i ng t i t e r s  o f  n e u t r a l i z i n g  a n t ibody a r e  
bene f i c i a l  ( Fi g u r e  4 ) . 
T r e a tme n t  f o r  H I V  s h o u l d  cont i nue t o  i n c l ude t h e  u s e  o f  
a n t ibodi e s  e s p ec i a l l y  t h o s e  which  may b e  neu t r a l i z i ng s i nce 
they may r e s u l t  i n  s ome p r o t e c t i on . Howeve r ,  we b e l i eve t ha t  
t h e s e  a n t ibod i e s  should b e  a l tered to  prevent i n t e r a c t ion w i t h  
F OC v i a  Fe o r  c omp l eme nt recept o r s . Vi r a l  immune c omp l e x e s  
w h i c h  do n o t  become t r apped on FOC d o  n o t  c o n t r i b u t e  t o  t h e  
e x i s t i ng r e s e rvoi r o f  v i r u s . I n s t e a d  t h e s e  comp l ex e s  m a y  b e  
c l e a red f r om t h e  s y s t em v i a  phagocyt o s i s . T h i s  t ype o f  
t he rapy may s l ow progre s s i on o f  t h e  di s e a s e  and d e l a y  onset  o f  
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A I DS . The v i r a l  bu rden w i t h i n  t h e  g e rminal  cen t e r  wou l d  t a ke 
l o n g e r  t o  deve l op t h e r e fore f o l l i c u l a r  hyperpl a s i a ,  
d e s t r u c t i on o f  FDC , and immunosupp r e s s i on l e a d i n g  t o  A I DS 
wou l d  be de l a yed . 
To be e f fe c t i ve , t r e a tmen t  a n t ibod i e s  should not bind t o  
Fe r e c e p t o r s . F o r  exampl e ,  Fab mo l e c u l e s  c o u l d  be p roduced 
f r om n e ut r a l i z i ng a n t i bod i e s . T h e s e  would b i nd t o  a nd 
n e u t r a l i z e t h e  v i r u s  i n  t h e  s ame ma nner  a s  who l e  a n t ibody . 
They could not ,  howeve r ,  b i nd to  FDC w i t hout t h e i r  Fe r e g i on . 
One p o t e n t i a l  d rawba c k  o f  Fab mol e c u l e s  i s  t he i r  s h o r t  h a l f  
l i fe . Al t e r n a t i ve l y ,  " de s i gn e r  a n t ibod i e s u  could b e  deve l oped 
w h i ch h a ve a mu t a t e d  Fe r e g i on . T h e s e  mo l e c u l e s  a g a i n  wou l d  
l a c k  t h e  ab i l i t y  to  b i nd Fe receptors b u t  t h e y  h a ve t h e  added 
ben e f i t  t h a t  they w i l l  rema i n  in ci rcul a t i on l onge r t h a n  Fab 
f r a gmen t s  and wi l l  therefore  be o f  g r e a t e r  c l i n i ca l  value . As 
p a t i e n t s  p r og r e s s  f r om H I V  a s ympt oma t i c  t o  A I DS t h e y  
e x pe r i e n ce a v a r i e t y  o f  imp a i rme n t s  i n  the  immune s y s t ems 
i n c l u d i n g  a de c l i n e  i n  n e u t r a l i z i ng a n t ibody t i t e r s . 
Immuni z a t i o n s  w i t h  the  d e s c r i bed de s i gn e r  a n t ibod i e s  i n  
c o n j unct i on w i t h  o t h e r  t r e a tmen t s  w h i c h  de c r e a s e  v i r a l  l o a d  
s uc h  a s  AZT , ddI , and prot e a s e  i n h i b i t o r s  m a y  p r o l on g  t h e  
c l i n i ca l l y  l a t e n t  s t a ge o f  d i s e a s e . 
T h e  r e s u l t s  reported h e r e  wi l l  b r i ng u s  c l o s e r  t o  
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unde r s t a n d i n g  h o w  t he v i rus i s  a b l e  to  u s e  t h e  h o s t  t o  i t s  
a d v a n t a g e . The f i nd i n g  t h a t  FDC a r e  a b l e  t o  conve r t  
n e u t r a l i z e d  v i r u s  i n t o  a n  i n f e c t ious  f o rm i n c r e a s e s  o u r  
u n de r s t anding  o f  H I V  pathogene s i s  and t h e  c l i n i ca l l y  l a t e n t  
s t a g e . T h e  imp l i ca t ions  o f  t h i s  r e s e a r c h  may h e l p  expl a i n  
f a i l u re i n  p revious  t rea tme n t  a n d  v a c c i n e  a t t empt s  a nd 
e n l i gh t e n  u s  t o  imp r oved de s i g n s  for  the  f u t u r e . 
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